Loma Linda University

TheScholarsRepository@LLU: Digital Archive of Research,
Scholarship & Creative Works
Loma Linda University Electronic Theses, Dissertations & Projects
1-2007

Predictability of Cardiovascular Disease Event Rates by Common
Carotid Artery Intima-Media Thickness in the Atherosclerosis Risk
in Communties (ARIC) Study
Mara Hollander

Follow this and additional works at: https://scholarsrepository.llu.edu/etd
Part of the Preventive Medicine Commons, and the Public Health Education and Promotion Commons

Recommended Citation
Hollander, Mara, "Predictability of Cardiovascular Disease Event Rates by Common Carotid Artery IntimaMedia Thickness in the Atherosclerosis Risk in Communties (ARIC) Study" (2007). Loma Linda University
Electronic Theses, Dissertations & Projects. 1389.
https://scholarsrepository.llu.edu/etd/1389

This Dissertation is brought to you for free and open access by TheScholarsRepository@LLU: Digital Archive of
Research, Scholarship & Creative Works. It has been accepted for inclusion in Loma Linda University Electronic
Theses, Dissertations & Projects by an authorized administrator of TheScholarsRepository@LLU: Digital Archive of
Research, Scholarship & Creative Works. For more information, please contact scholarsrepository@llu.edu.

LOMA LINDA UNIVERSITY
School of Public Health

PREDICTABILITY OF CARDIOVASCULAR DISEASE EVENT RATES
BY COMMON CAROTID ARTERY INTIMA-MEDIA THICKNESS IN
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY

by
Mara Hollander

A Dissertation in Partial Fulfillment of the
Requirements for the
Degree of Doctor of Public Health
In Preventive Care

January, 2007

©2007

Mara Hollander

Each person whose signature appears below certifies that this dissertation, in his/her
opinion, is adequate in the scope and quality as a dissertation for the degree of Doctor of
Public Health.

Susanne Montgomery, Chairperson
Professor of Health Promotion and Education

Brenda Rea
Assistant Professor of Health Promotion and Education

Dr. Helmuth Fritz, MD, RVT

n

ABSTRACT OF THE DISSERTATION
Predictability of Cardiovascular Disease Event Rates by Common Carotid Artery IntimaMedia Thickness Sampling in the Atherosclerosis Risk in Communities (ARIC) Study
by
Mara Hollander MS, RPT
Doctor of Public Health Candidate in Preventive Care
Loma Linda University, 2007
Dr. Susanne Montgomery, Chairperson

Background: Carotid artery intima media thickness (IMT) is a non-invasive
reliable predictor of the extent and severity of CVD. There is difficulty acquiring all
measurements for validated three-site carotid IMT. More accessible one-site common
carotid artery (CCA) IMT has not yet been validated with CVD events.
Purpose: This study will evaluate the diagnostic accuracy of one-site CCA IMT
compared to three-site IMT in predicting cardiovascular disease (CVD) events.
Assessment of whether the association of incremental one-site CCA IMT to a CVD event
is significant with and without adjustment for traditional cardiac risk factors was made.
Methodology: Data from The Atherosclerosis Risk in Communities (ARIC)
Study was analyzed for this secondary analysis research study. The study sample utilized
only participants for whom raw values were obtained (n=4974). A second sample with
raw values which excluded all values <.5 mm IMT was also used (n=4366).
m

Analysis: Receiver Operator Characteristic (ROC) curves were used to determine
diagnostic accuracy of one-site CCA vs. three-site IMT in predicting CVD events. Age
and gender-specific logistic regression analysis were used to compare the relative
incidence of CVD for incrementally different levels of one-site CCA IMT and three-site
IMT, with and without adjustment for risk factors.
Major Findings: ROC curve AUCs demonstrated CCA one-site and three-site
IMT to be similarly predictive of CVD event. Odds ratio comparisons of one-site IMT to
CVD event showed no association for women, however, for three-site IMT there was a
strong association, and this value was profoundly affected by exclusion of values <.5mm
and by risk factor adjustment. For men, both one-site and three-site IMT were associated
with CVD event similarly.
Other Findings: Only IMT measures and diabetes for women were found to
have association to CVD events in final sample.
Significance to the Field of Preventive Care: The common carotid artery mean
IMT is easier to analyze than other carotid IMT sites but this site alone was not shown to
be an adequately robust predictor of CVD event risk. Further study must be done to find
a robust predictor of CVD events, so that preventive care specialists may clinically use
this tool.
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CHAPTER 1
INTRODUCTION

A. Statement of the Problem
Coronary heart disease (CHD) is projected by 2020 to become the leading cause
of death in all developing countries. Atherosclerosis is an insidious disease process that
frequently results in cardiovascular disease (CVD) including coronary heart disease
(CHD). Sixty-five million Americans have atherosclerosis, but more than one-third of
these people (25 million) are unaware they have it (Association for Eradication of Heart
Attack [AEHA], 2005). Typically those unaware, and who are asymptomatic, will
remain naive until a CHD event occurs (AEHA, 2005). By then, significant damage or
disability will have occurred. The first manifestation of CHD in about 50% of
individuals is acute MI or sudden death (Tsimikas & Witzum, 2002). Early awareness
and treatment of atherosclerotic status, before a CHD or other CVD event occurs, is
therefore critical.
Researchers and clinicians have developed and utilized various tools to measure
atherosclerosis. Initially, assessment of arterial wall atherosclerosis was restricted to
pathologic and angiographic studies, both accurate but also invasive techniques. As early
as the 1970’s, diagnostic vascular ultrasound, a non-invasive technique to visualize the
arterial wall, began to be used (O’Leary & Polak, 2002). Carotid ultrasound scanning is a
non-invasive imaging technique found to be effective, valid, and reliable in ascertaining
extent and severity of atherosclerotic disease in the carotid arteries (O’Leary & Polak,
1

2002). Measurement of the intimal medial thickness (IMT) on brightness-mode
ultrasound was found not to significantly differ from intimal medial thickness measured
on pathologic examination (Pignoli, Tremoli, Poli, Oreste & Paoletti, 1986). More
recently, Schulte-Altedomeburg et al. (2001) found B-mode ultrasound to provide a
reliable approach for in vivo identification of cross-sectional area and, less precisely,
lumen diameter of common carotid artery. This was true despite in vivo measurements
being systematically larger than histological measurements, presumably due to tissue
fixation and processing (Schulte-Altedomeburg et al., 2001). It also reflects the severity
and extent of atherosclerotic disease in the coronary and other arteries throughout the
body when measured by intravascular ultrasound (r=0.46 to 0.57) (Crouse, 2001; Pit’ha,
Krajickova,, & Cifkova, 1999). It reflects the same degree of correlation with coronary
artery atherosclerosis as the degree of correlation of atherosclerosis that exists between
the right and left coronary arteries based on pathologic tissue analysis. Carotid
ultrasound is routinely used worldwide to determine extent of carotid artery disease in
patients presenting with symptoms suggesting cerebral vascular flow limiting stenosis
and to monitor changes in response to medical or surgical treatment. Carotid IMT is a
refined aspect of the standard carotid ultrasound test that is now increasingly being used
to ascertain cardiovascular status in selected asymptomatic individuals, prior to
development of clinical signs or symptoms of atherosclerosis (Greenland et al., 2000).
A diagnostic ultrasound scanning device utilizes sonic waves to measure
atherosclerotic wall thickness and also can detect and measure atherosclerotic changes
over time to quantify progression or regression of atherosclerosis (O’Leary & Polak,
2002; Crouse, 2001). Validity of this approach has been demonstrated by a variety of
2

means (Riley, 2002). Both in vitro and in vivo pathohistologic measurements of
atherosclerosis correlate very well to all three sites of carotid artery three-site IMT
measurements by ultrasound (Crouse, 2001). These three sites are the common carotid
artery (CCA), the bifurcation (BIF), and the internal carotid artery (ICA). Positive
atherosclerotic associations utilizing these three sites have been validated by numerous
investigators (del Sol, Bots, Grobbee, Hofman, & Witteman, 2002; Hodis et al., 1998).
Carotid IMT is not only a significant marker of early atherosclerosis, it is also an
independent risk factor for both cardiac infarction and stroke (Crouse, 2001; O’Leary et
al., 1999). Results from the Atherosclerosis Risk in Community Study (ARIC)
(Chambless et al., 2002) demonstrated a strong and graded relationship between the
incidence of coronary artery disease and carotid IMT. Carotid IMT scanning
demonstrates predictive power to alert patients and their physicians to cardiovascular
disease event risk thereby permitting stratification or staging of asymptomatic patients in
primary prevention (Mitka, 2003).
The association of CHD incident rate and three-site mean carotid IMT for a large
population of asymptomatic men and women ages 45-65 has been shown and
documented in the Atherosclerosis Risk in Community (ARIC) Study (Chambless et al.,
1997). Carotid three-site mean IMT scanning is a safe, inexpensive, precise and
reproducible measure (Aminbakhsh & Mancini, 1999). There are, however, some
difficulties associated with three-site carotid mean IMT scanning measurements. Ideally,
a full 10 mm portion of each segment is required to adequately acquire mean IMT
measurement. These three sites have different levels of visualizability based on the way
carotid artery is shaped and positioned. The common carotid artery (CCA) is most
3

superficial and most accessible as compared to the bifurcation and the internal carotid
arteries. The bifurcation (BIF) has nonparallel, non-horizontal walls located more
distally and deeper in the neck, further from the skin surface, making it harder to
consistently visualize full 10 mm long segments of IMT suitable to measure mean
bifurcation IMT (del Sol et ah, 2002; Howard et ah, 1993). The internal carotid artery
(ICA), a more distal extension from the bifurcation, is usually farthest from the surface of
the neck and frequently tortuous, again limiting the ability to visualize full 10 mm long
segments of IMT suitable to measure mean ICA IMT. Due to these conditions,
visualizability, meaning the percentage of time that accurate visibility of the required 10
mm long segment is achieved, is 49% for internal carotid artery, 75% for the bifurcation,
and 91% for the common carotid artery (Howard et ah). As a result of the low visibility
of the bifurcation and especially the internal carotid arteries, researchers in the ARIC
Study decided to impute a substantial percentage of their values (Chambless et ah, 1997).
The common carotid artery mean IMT is more easily visualizable, imaged, and measured
than that of other carotid sites, making measurement more reliable (Howard et ah, 1993).
IMT investigators in the Rotterdam Study found a close association of three-site
mean maximal measurement and the mean maximal measurement of solely the CCA
mean IMT (del Sol et ah, 2002), but they did not report their results in terms of mean
IMT values for three-site or solely the CCA. It would facilitate utilization of carotid IMT
ultrasound scanning for measurement of atherosclerotic disease progression if the
clinician was only required to access one-site measurement of carotid artery IMT for
CVD predictive value that was equivalently or even superiorly robust to the three site
measurements. However, to validate such an abbreviated scan, and make it potentially
4

clinically useful, it is first necessary to provide documented evidence of the comparison
of the relationship of the isolated CCA mean IMT and CVD incidence rate, to the
documented rate of the previously used and proven three-site mean IMT relationship to
CVD incidence. It has not been documented how the incremental CCA mean IMT event
rates correlate to known CVD events, with and without adjustment for selected risk
factors. This study will provide that documentation. This study will also compare these
one-site results to comparable 3-site values of association to CVD event rate.
B. Purpose of the Study
The primary purpose of this study is to use data from the ARIC Study to
determine if, among asymptomatic men and women 45-65 years of age, one-site CCA
mean IMT is an adequately robust predictor of CVD incidence rates. The secondary
purpose is to determine if the strength of the association of incremental CCA one-site
mean IMT and of the incremental three-site mean IMT to CVD events is significant and
remains so when adjusted for selected cardiovascular risk factors.
C. Research Questions
1. How robustly predictive of CVD is one-site mean IMT, and how does three-site
mean IMT predictivity of CVD compare?
2. What is the risk of a CVD event for those at five different incremental levels of a
common carotid artery one-site average right and left far-wall mean IMT, alone
and after adjusting for potential confounding factors collected in the ARIC Study?
How does incremental one-site IMT compare to incremental three-site IMT in
association to CVD event rate? Selected potential confounding factors collected
in the ARIC Study include: total serum cholesterol (TSC), low density lipoprotein
5

cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C), triglycerides,
fibrinogen, hypertension, body mass index (BMI), obesity, diabetes, sports
activity, smoking, cigarette-years, and ethanol.
D. Mechanism of Atherosclerosis
Atherosclerosis, from the Greek meaning fat (i.e. athere [gruel]) and thickening of
the arterial intima (i.e. sclerosis [hardening]), is a disease process that begins in the inner
most or endothelial layer of the artery. The endothelium is an organ composed of a
single cell layer that lines the intimal surface of the arteries and therefore functions as an
interface between circulating blood and the tissues of the body. The endothelial cells
synthesize a variety of substances which serve autocrine and paracrine functions
(Wheaton & Pinkstaff, 2006). A healthy endothelial layer is thrombo-resistant because
of the production of eicosanoids and heparan sulfate, which respectively inhibit platelet
adhesion and thrombin activation (Ettensen, Koo, Januzzi, & Edelman, 2000). Since a
primary function of endothelium is to provide this nonthrombogenic surface, eicosanoids
and prostaglandins are produced. An example of a prostaglandin is prostacyclin, which
functions to vasodilate blood vessels and to inhibit platelet aggregation. Also important
is endothelial production of a surface covering of heparan sulfate. Like heparin, which is
a more specific member of this widely distributed class of compounds, heparan sulfate
inhibits thrombosis. Unlike heparin, which is found almost exclusively in mast cells,
heparan sulfate is found throughout all tissues, most prominently on cell surfaces
(Nugent, 2000). Heparan sulfate also inhibits inflammatory cell proliferation and
neointimal thickening (Clowes & Kamovsky, 1977; Castellot et al., 1981; Edelman et al.,
1990; Ettenson et al.). Another primary endothelial function is to promote vasodilation
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through endothelium-derived relaxing factor (EDRF), which is nitric oxide (NO) or a
thiol of NO (Rhodes & Pflanzer, 2000). Endothelial function also includes secreting
vasoconstrictive factors such as endothelin, angiotensin II (A-II), serotonin, and plateletderived growth factor, which are important in vasoconstriction. Endothelium also has the
important function of secretion of various cytokines and adhesion molecules, such as
vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, utilized when
the endothelium is damaged (Wheaton & Pinkstaff, 2006). When endothelial damage
occurs it may increase permeability to lipoproteins, decrease nitric oxide production,
increase leukocyte migration and adhesion, allow prothrombotic dominance, stimulate
vascular growth and allow release of vasoactive substances (Wheaton & Pinkstaff).
Endothelial dysfunction is the first step in the process that allows lipids and
inflammatory cells (monocytes and T lymphocytes) from the blood flow into the
endothelial and sub endothelial spaces (Hansson et ah, 2006). When levels of LDL are
within normal ranges in the blood, a healthy endothelium is able to eliminate LDL via
reverse transport and other processes. Excessively high cholesterol in the form of very
low density lipoprotein-cholesterol (VLDL) or low density lipoprotein-cholesterol (LDL)
may, by overwhelming these mechanisms, cause infiltration of LDL into the endothelial
wall at a rate greater than elimination is possible. The subsequent retention of LDL in the
sub-endothelial space is followed by enzymatic attack and LDL oxidation.
Atherosclerotic endothelial activation is also more likely to occur at areas in the arteries
that experience greater hemodynamic stress via hypertension. In response there is both
an impairment of the normal function of the endothelium and development of chronic
inflammation (Hansson et al., 2006).
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With injury induced inflammation, activated endothelial cells produce
chemokines and leukocyte adhesion molecules that are expressed on the vascular surface
and cause the attraction and adherence of monocytes, T cells and platelets (Hansson et
al., 2006). Monocytes and T cells are stimulated to alleviate the endothelial injury while
pro-inflammatory cytokines and chemokines such as IL-1 and leukocyte cell adhesion
molecule (CAD) then attract more leukocytes into the intima (Wheaton & Pinkstaff,
2006). These cells penetrate the endothelium and invade the intimal (next most inner)
layer. This is where the monocytes become macrophages with up-regulated scavenger
receptors and toll-like receptors on their surface. The scavenger receptors mediate
acquisition and ingestion of oxidized LDL and other foreign substances by the phagocyte.
The cholesterol within the LDL-C encourages the transformation of phagocytes to foam
cells. These unhealthy foam cells attract even more monocytes, leading to the
development of a fatty streak, which is the precursor to plaque (Hansson et al., 2006).
Toll-like receptors on the macrophage surface activate the release of cytokines,
proteases, and vasoactive molecules within this inflammatory response. Within the
lesion, T cells recognize that there are antigens and this recognition initiates Th-1
responses. These include release of pro-inflammatory cytokines such as IFN-y (Inter
Feron-Gamma) and TNF-(3 (Tumor Necrosing Factor- Beta) (Hansson et al., 2006).
These participate in the local inflammatory process by stimulating macrophages, vascular
endothelial cells, and smooth muscle cells to produce TNF-a (Tumor Necrosing FactorAlpha), which along with IFN-y stimulates IL-6 (interleukin-6). IL-6 produces Creactive protein (CRP), an inflammatory marker, within the liver as a response. Creactive protein is also produced in atherosclerotic arteries and this exacerbates the
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atherosclerotic process (Jialal, Devaraj & Singh, 2006). This promotion of CRP occurs by
stimulating adhesion and migration of leukocytes, and by suppressing nitric oxide (NO)
production (Wheaton & Pinkstaff, 2006). Nitric oxide (NO) is a vasoactive molecule and
has a critical role in atherosclerosis. Nitric oxide normally preserves endothelial health
by inhibiting smooth muscle cell growth, platelet aggregation, monocyte adhesion, local
inflammation, and oxidation. Without nitric oxide, these functions are no longer
inhibited. Additionally, when nitric oxide is suppressed, there is reduced vasodilation
causing increased arterial stress (Wheaton & Pinkstaff, 2006).
The injured endothelium then attracts platelets and begins to release growth
factors that stimulate the movement of smooth muscle cells from the medial layer into the
intima, where they proliferate abnormally. Reduced nitric oxide means less inhibition of
these cells. These smooth muscle cells, along with the phagocyte scavengers, release
collagen and other proteins to form the fibrous portion of plaque. This plaque, over time,
becomes hardened, thus giving this dynamic the name atherosclerosis, or hardening of
the arteries. In addition to increasing hardness, the process causes a thickening of the
intimal-medial layer as smooth muscle cells, phagocytes, cholesterol debris, and fibrous
proteins proliferate and collect. It is the arterial wall thickening that indicates degree of
atherosclerotic disease, and it is the thickening in the carotid artery that the carotid IMT
ultrasound scanning procedure measures (Chambless et al., 1997). Schillinger et al.
(2005) found that a close temporal correlation exists between inflammation and
progressive carotid atherosclerosis as measured by carotid IMT scanning. In progression
of atherosclerotic disease, inflammation of these plaques leads to protease secretion,
tissue destruction, and ultimately rupture of the plaque. This may lead to emboli,
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ischemia and/or infarction (Hannson et al, 2006). It is because of the association of
coronary heart and other cardiovascular disease to atherosclerosis, which is reflected in
carotid artery IMT, that this study was developed to determine a more feasible, though
scientifically valid, method of clinically measuring carotid IMT.
E. Mechanisms of Risk Factors Selected in ARIC Study Which Are Associated with
Atherosclerosis
There are a variety of physiologic states or behavior patterns that increase the risk
of developing CHD, some of which are significant enough to be considered risk factors
for CHD. Among these are the risk factors that were available and measured in the ARIC
study. These include high levels of low-density lipoproteins cholesterol (LDL-C), low
levels of high density lipoproteins cholesterol (HDL-C), high levels of total cholesterol,
high triglycerides, hypertension, body mass index (BMI), obesity, diabetes, smoking,
pack years of smoking, sports activity level, alcohol consumption, and fibrinogen levels
(Framingham, 2006). These risk factors have each been shown to be associated with
CHD to varying degrees (Framingham, 2006). It is because of these established
associations that ARIC Investigators (1987) chose to examine these risk factors in
association with carotid IMT and CHD event. For example, hypertension, high serum
cholesterol levels (especially LDL-C), and oxidized LDL-C disrupt endothelial functions
and therefore promote degeneration of the endothelium which, as indicated above, is an
initial step in atherosclerosis-related CHD (Rubin & Farber, 1999).
Selected risk factor mechanisms as they pertain to the process of atherosclerosis
will be discussed below, along with those of two other important risk factors which were
not available or considered at the time of the study, high CRP and homocysteine. A
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relationship also has been shown between risk factors and three-site carotid artery mean
IMT and coronary heart disease event rates (Chambless et al., 1997). The Rotterdam
Study (del Sol et al., 2002) additionally showed a relationship between one-site mean
maximum IMT measurements of the CCA, BIF, and ICA, and risk factors and CHD
event rates. This study will examine what the risk of CVD is for those at five different
incremental levels of one-site mean common carotid artery average right and left far-wall
IMT, alone and after adjusting for potential confounding selected risk factors chosen by
the ARIC Study. The manifestations of selected CVD risk factors in carotid intima-media
thickening (IMT) will be discussed in Chapter 2. The basic mechanisms by which these
risk factors affect the atherosclerotic process will be discussed below.
1. Lipoprotein-Cholesterol
Lipid levels, including high levels of low-density lipoprotein-cholesterol (LDLC), low levels of high density lipoprotein-cholesterol (HDL-C), and total serum
cholesterol (TSC), increase atherosclerosis (NCEP, 2001). TSC is a measure of the
composite of total cholesterol contained in each of the different lipoproteins (average
range of this value is considered to be 200mg/dl), and while it is a useful tool for general
screening use, since LDL-C and HDL-C have opposing functions, cholesterol distribution
among each lipoprotein type is a more powerful predictor of cardiovascular risk
(McArdle, Katch, & Katch, 2001).
Cholesterol can be both exogenous and endogenous. Dietary cholesterol is
absorbed into intestinal cells where it is combined with triglycerides and phospholipids
into chylomicrons. The chylomicrons are released into the lymphatic system and then
into the bloodstream at the thoracic duct. From that point on they distribute both their
11

triglyceride and cholesterol content throughout the body, with whatever remains ending
up at the liver.
Meanwhile at the liver, endogenous cholesterol is being made from chylomicron
remnants, other fatty acids, carbohydrate, protein, or alcohol breakdown (Champe,
Harvey & Ferrier, 2005). The lipids are then sent out in protein packages, together called
lipoproteins. Very low density lipoproteins readily give triglycerides to cells, resulting in
low density lipoproteins (LDL-C). These LDL-C molecules have a cholesterol-rich
composition. LDL-C molecules travel through the bloodstream releasing cholesterol,
triglycerides, and phospoholipids to all tissue cells in the body.
Some LDL-C permeates the blood vessel wall endothelium and is utilized there.
When the homeostatic endothelial system is in balance, LDL-C normally diffuses into the
endothelium and then any excess is eradicated (Hannson et al., 2006). However, when
concentrations of LDL-C are elevated in the bloodstream, the endothelium receives a
greater amount of the cholesterol and is unable to remove the excess substance quickly
enough, which results in its endothelial accumulation. This accumulated lipoprotein is
then oxidized by free radicals, and consequently attacked by the macrophages as a
foreign invader. It is the LDL-C that, when oxidized and phagocytized by macrophages
results in macrophages transforming into foam cells. These foam cells may then form
fatty streaks and then eventually plaque. If the level of LDL-C remains higher, there is
greater likelihood of transformation into the plaque that characterizes atherosclerosis
(Wheaton & Pinkstaff, 2006). Additionally, oxidized LDL has been shown to
downregulate the enzyme which produces endothelial nitric oxide, endothelial nitric
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oxide synthetase (eNOS) (Jialal, Devaraj, & Venugopal, 2002). Nitric oxide is critical in
maintaining endothelial health (Wheaton & Pinkstaff, 2006).
On the other hand, high-density lipoproteins are protective. There is evidence that
the relationship is one of cause and effect, with increasing levels of HDL-C lowering the
level of atherosclerotic plaque (Barter, 2005). The primary mechanism by which HDL-C
influences atherosclerosis is by a process known as reverse transport of cholesterol, in
which the HDL extracts excess cholesterol deposited in the artery walls and delivers it to
the liver. This cholesterol is then eliminated by the gastrointestinal tract (Toth, 2005).
This efflux is the only mechanism by which cellular cholesterol accumulation can be
limited or reversed by the macrophages (Eckardstein von, Hersberger, & Rohrer, 2005).
HDL has anti-oxidative ability, as lipophilic antioxidants may be carried by HDL and can
then scavenge free radicals, a process which interrupts the LDL oxidation cascade
(Eckardstein von et al.). HDL also has a component called paraoxonase which is known
to inhibit the oxidative modification of LDL by inhibiting formation of foam cells
(Mackness, Durrington, & Mackness, 2004), allowing HDL promoted cholesterol efflux.
HDL can also function to inhibit adhesion molecule expression, so that fewer monocytes
are attracted for entry into the endothelium (Barter, 2005).
2. Triglycerides
Triglycerides, composed of glycerol and three fatty acids, are the primary form of
dietary fat (95%) and fat storage (99%) in the body (Whitney, Cataldo, & Rolfes, 2002).
One ultimate goal of digestion is ultimately to break down and utilize the components of
triglycerides. If the fatty acids attached to the glycerol are short or medium-chained they
can be immediately absorbed in the intestine to the blood stream (utilizing the enzymes
13

lingual and gastric lipase). When the triglyceride is composed of longer chains, they
must utilize bile to form micelles, which then may be transported into the intestines.
Once in the intestine, the triglycerides re-assembled and are packaged into chylomicrons
along with cholesterol and phospholipids. These chylomicrons travel through the
lymphatic system to the thoracic lymphatic duct, effectively bypassing the liver. They
are then released into the bloodstream, to be utilized by cells of the body. As the
chylomicrons travel in the vessels past various parts of the body, these dietary
triglycerides are removed from the blood to be utilized by cells, and the chylomicron gets
smaller and smaller. It takes approximately 14 hours for the chylomicrons to travel to the
liver where they are absorbed as remnants and then processed into new triglycerides.
These new triglycerides are packaged with proteins, cholesterol and phospholipids to
become lipoprotein-cholesterol. The VLDL have the highest proportion of triglycerides
at 50%. LDL and HDL have 10% and 5% triglycerides respectively (Champe et al.,
2005). The lipoproteins have cholesterol inversely related to these associated levels of
triglycerides.
When triglycerides are traveling in the bloodstream, adipose cells may utilize
their lipoprotein lipase (LPL) to grasp the passing triglycerides. The triglycerides are
broken down for entry, and then reassembled inside the adipose cell where they can be
tightly stored. When triglycerides are needed for cell energy, hormone-sensitive lipase
(HSL) within the adipose cell disassembles the unit into glycerol and fatty acids, and
releases them from the cell. These components are utilized by a variety of body cells in
the Kreb’s Cycle for energy.
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In 1977, the Framingham Study (2006) identified triglycerides, along with both
LDL-C and HDL-C, as having a negative association with CHD. A study by Iso et al.
(2001) demonstrated non-fasting serum triglycerides predict the incidence of coronary
heart disease in Japanese men and women whose total cholesterol had low mean values.
Typically, though, triglyceride levels are measured after a 12 hour fast, as with other
blood lipids. Accurate triglyceride measurement is elusive, however, as triglyceride
concentrations vary more than other lipids, and therefore impractical repeated
measurements after a 12 hour fast would be required (Garber & Avins, 1994). As a
result, other blood lipid concentration measurements are more frequently utilized.
3. Hypertension
Hypertension, or high blood pressure at a level of 140 mmHg systolic or 90
mmHg diastolic (Chobanian, Bakris, Black & Cushman, 2003), exacerbates the
atherosclerotic process (Framingham, 2006). Hypertension is associated with a 47%
increased risk of CVD event (Wattanakit, Folsom, Chambless, & Nieto, 2005). As blood
pressure increases, it exerts increased sheer stress on the walls of the arteries, which may
cause tiny tears or weak places in the artery (Eckardstein von et al., 2005). This effect is
more likely to occur at angulated or branch points in the blood vessel. The artery in
stressed locations is more vulnerable to atherogenic lipids and toxins (Hansson et al.
2006). Hypertensive patients have been shown to have greater rates of blood pressure
fluctuation, which increases vessel wall stress and may participate in medial hypertrophy
(Zakopoulous et al. 2005).
Hypertension introduces non-hemodynamic elements such as increased
endothelial permeability for collagen and elastin, and endothelial platelet and monocyte
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accumulation as a result of endothelial dysfunction (NHLBI, 1998). Other endothelial
dysfunctions induced by hypertension include reduced NO mediated vasodilation and
increased vascular resistance, possibly due to reduced NO synthetase or excess
production of free radicals which would inhibit NO production (Jialal, Venugopal, et ah,
2002). Decreased NO activity can promote an inflammatory response such as vessel wall
platelet adhesion and proliferation of smooth muscle cells. Many of these vascular
processes affect hypertension and atherosclerosis, with hypertension accelerating and
intensifying the process of atherosclerosis in a synergistic manner (NHLBI, 1998).
4. Body Mass Index and Obesity
Body Mass Index (BMI) is a ratio of weight to height with weight in kilograms
divided by the square of the height in meters. BMI reference standards and “cut-points”
are established from mortality and morbidity data (Dalton, 1997). High BMI has been
shown to increase risk of CHD (Nieman, 1999). Obesity, (from the Latin obesus
meaning fat), is clinically defined as an excess of body fat with a BMI over 30, and is
linked to atherosclerosis and thereby CHD (Framingham, 2006). Obesity, as reflected by
the indirect measure of BMI, is indirectly linked to atherosclerosis by a variety of
mechanisms. These include increased blood pressure, increased LDL-cholesterol,
decreased HDL-cholesterol, and increased triglyercides (Andersen, Wadden, Bartlett,
Vogt, & Weinstock, 1995; Nieman, 1999). These lipid states are all associated with
increased risk of CHD, as previously stated.
Adipocytes are the source of proinflammatory mediators such as TNFa, IL-6,
leptin, plasminogen activator inhibitor (PAI-1), resistin, and CRP. All of these mediators
promote endothelial dysfunction, insulin resistance, and atherosclerosis (Lau, Dhillon,
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Yan, Szmitko, & Verma, 2005). Although circulating adipokine levels are generally
elevated in the obese, visceral fat appears to produce at least some of the adipokines in
larger amounts than other fat depots (Wajchenberg, 2000; Lau et al, 2005.). When
weight loss occurs, there is a decrease in serum levels of most of the adipokines, showing
a direct relationship between obesity and inflammatory adipokines, and an indication of
the association between obesity and atherosclerosis (Lau et al., 2005).
A study by Manson et al. (1990), involving over 115,000 nurses over an eight
year period, showed that CHD more than tripled in those who had a BMI of over 29
versus those with a BMI of less than 21. Furthermore, mortality due to CHD was
estimated to be almost 90% higher in those with severe obesity, defined as a BMI of 35
(Manson et al., 1990; Nieman, 1999; Dalton, 1997). Another study of almost 30,000
male professionals (Rimm et al., 1995; Nieman) confirmed that as body mass increases,
CHD incidence rises. In a recent study by Hu et al. (2005), the authors concluded that
maintaining a normal weight is an important indicator for decreased risk of mortality
from all causes.
5. Diabetes
Diabetes has reached an epidemic level, affecting more than 8.6 million people in
the United States (Center for Disease Control, 2006). Numerous studies show that
diabetes is linked to an increased risk of incidence of CHD, with diabetic adults
experiencing a death rate due to heart disease about two to four times the rate of non
diabetic adults (Nieman, 1999). At the time an adult is diagnosed as having type II
diabetes, risk for MI; is already considered “high” or equivalent to that of a non-diabetic
who has already had a prior MI; the national cholesterol education program therefore
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considers diabetes to be a coronary artery disease risk equivalent and not just a risk factor
for CHD (National Cholesterol Education Program, 2001). When diagnosed with
diabetes at 60 years of age, male life expectancy is reduced by 7.3 years, and female life
expectancy is reduced by 9.5 years (Wheaton & Pinkstaff, 2006). Wattanakit, Folsom,
Chambless and Nieto (2005) found that diabetes increased the CHD event rate by 65%.
Vascular dysfunction, an early event in atherosclerosis, is found in young adults with
type I diabetes (Clarkson et al., 1996). Diabetes causes metabolic abnormalities
inducing vascular dysfunctions such as decreased NO, increased NF-kB (nuclear factor
Kappa Beta, a cytokine gene inducer) (Nickoloff) and increased endothelin-1, a
vasoconstrictor (Beckman, Creager, & Libby, 2002). These dysfunctions lead to vascular
inflammatory reactions such as cytokine release and cellular adhesion molecule
expression, which are immediate precursors to atherogenesis (Beckman et al., 2002).
Insulin resistance and hyperinsulinemia, precursors of type II diabetes, are
thought to cause dysfunction of the endothelium, such as mitogenic influence on the
smooth muscle cells of the blood vessel (Lau et al, 2005). Hyperglycemia also induces
endothelial free radical production and activation of NF-kB, and enhances production of
advanced glycation end-products (AGEs) (Lau et al., 2005). AGE accumulation, along
with hyperglycemia, is associated with increased expression of genes involved in
transcription of NF-kB (Beckman et al., 2002), and in activator protein 1 (AP-1)
(Wheaton & Pinkstaff, 2006). This inflammatory gene expression promotes leukocyteattracting chemokine production, inflammatory cytokine production, and increased
cellular adhesion molecule production (Wheaton & Pinkstaff, 2006). When this
dysfunction is chronic, it is associated with many inflammatory diseases such as
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atherosclerosis (Beckman et al, 2002). One of the results is a promotion of lipoprotein
oxidation, which is a primary contributor of atherogenesis. Additionally, the
hyperglycemia intrinsic in type II diabetes is frequently associated with obesity.
Hyperglycemia increases expression of adipokines, which enhances the adipokine-related
endothelial dysfunction cycle (Lau et al., 2005).
1. Smoking
Smoking, as well as number of pack years for smoking, is linked strongly to
CHD. Smoking is associated with a 67% increased CHD event rate (Wattanakit, Folsom,
Chambless & Nieto, 2005). Smoking is not only an independent risk factor for
atherosclerotic disease, but is associated with a 50% increase in the progression of
atherosclerosis compared to non-smokers (Howard et al., 1998). Pack years of smoking
were independently associated with faster progression of CHD (Waters et al., 1996).
The mechanism by which smoking affects atherosclerosis is not fully understood,
in part because it has a variety of effects (Ambrose & Barua, 2004). Smoking is
associated with elevated LDL-cholesterol and decreased HDL-cholesterol levels (Rubin
& Farber, 1999). Smoking increases both platelet activity and catechoamine levels. The
metabolites of cigarette smoke include allylamine and acrolein end-products, as well as
reactive oxygen species, all of which are free radicals (Ambrose & Barua; Zimmerman &
McGeachie, 1987). This produces free radical damage of lipids, promoting oxidation of
LDL-cholesterol. Vascular wall damage via this LDL oxidation may lead to impaired
prostacyclin production, which can work to reduce the elastic properties of vascular
vessels. Smoking also increases plasma concentration of fibrinogen, which is
atherogenic (Martinez-Villa et al., 2003). Kullo and Ballantyne (2005) showed that
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plasma fibrinogen levels and smoking are dose-related, and that high fibrinogen levels
due to smoking are reversible with smoking cessation.
7. Sports Activity Level
A variety of physical activity measures have been used to show the association of
physical inactivity to atherosclerosis and CHD. A study done at the Cooper Institute
(LaMonte, 2004) demonstrated that various leisure time physical activities, such as
walking and stair climbing, were protective of carotid atherosclerosis progression,
independent of other risk factors. Exercise measures such as treadmill performance have
been used to reflect habitual physical activity, and this objective testing shows a strong
association to CHD (Thompson et al., 2003). Whether subjectively or objectively
measured, the causal relationship between physical activity and coronary artery disease
remains strong, with most physically active subjects generally demonstrating CHD rates
half of those of the most sedentary group (Thompson et al., 2003). The positive impact
physical activity has on CHD occurs at an early age. A study of 853 middle-aged men
(42-60 years of age) by Lakka et al. (2002), showed that good cardiorespiratory fitness is
associated with slower progression of early atherosclerosis for middle-aged men.
The precise mechanisms by which physical activity affects the endothelium are
being examined. A Stanford study with mice showed that by blocking the production of
nitric oxide in cases of genetic hypercholesterolemic mice, promotion of atherogenesis
which would normally occur could be counteracted and reversed with chronic exercise
training (Niebauer et al., 2003). Further, exercise training may halt and even reverse
atherosclerosis by inducing atheroprotective phenotypes in endothelial and T cells, such
as downregulating leukocyte adhesion and chemotactic molecules (Smith, 2001).
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Hambrecht, Wolf, and Gielen (2000), in a study to determine the effects of exercise
training on endothelium-dependent vasodilation of coronary vessels, found
atheroprotective changes in hemodynamic stress on coronary endothelium to be due to
exercise.
In addition to producing atheroprotective effects independently, physical activity
plays both a preventive and therapeutic role in relation to a variety of atherosclerotic risk
factors (Smith, 2001). These include raising levels of HDL-cholesterol, lowering
hypertension, reducing obesity, and reducing insulin resistance, a major element of
diabetes (Thompson et al., 2003). Triglyceride levels and LDL cholesterol levels are also
lowered with exercise (Smith, 2001). Therefore, physical activity reduces morbidity and
mortality associated with atherosclerosis by influencing endothelium directly, and by
positively influencing risk factor modification indirectly (Smith, 2001). The Center for
Disease Control (CDC) and the American College of Sports Medicine (ACSM) jointly
concluded from a review of pertinent physiological, epidemiological, and clinical
evidence, as well as research and review articles, that 30 minutes of moderate exercise a
day is important for health promotion and disease prevention (Pate et al., 1995).
The ARIC Investigators chose to look at a sports activity index to reflect physical
activity, which is an established risk factor for atherosclerosis and carotid IMT (Baecke,
Burema & Friijters, 1982). The considerations for the ARIC study definition of sports
activity were threefold: 1) physical activity at work; 2) sport during leisure-time; and 3)
other physical activity during leisure time. Sports activity level, as defined in the ARIC
study, was rated from 1 (low) to 5 (high). These specifications were made so that an
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accurate assessment could be made about each participant’s actual “habitual physical
activity” (Baecke, Burema, & Friijters, 1982).
8. Ethanol
Ethanol, or alcohol, consumption is considered mild to moderate up to 40 grams
of ethanol per day. Ethanol consumption at this level has been linked to decreased
incidence of CHD, in part because alcohol has been shown to dilate arteries and increase
blood flow (Goldberg, Mosca, Piano, & Fisher, 2001), but more strongly because there is
a positive correlation between moderate alcohol consumption and the plasma
concentration of HDL-C (Harvey, 2005). Another way to state this is two drinks per day
for men and one drink per day for women may be cardioprotective. A “drink” usually
contains .5 ounces of pure ethanol or 12-14 grams of alcohol, as usually contained in 4
ounces of wine, 12 ounces of beer or 1.5 ounces of hard alcohol. In addition to raising
levels of HDL-C, moderate alcohol consumption positively alters blood clotting factors
such as fibrinogen and clotting factor VII, reducing possibility of the formation of small
blood clots which might block coronary or other blood vessels. In more than 100
prospective studies, this inverse association between moderate drinking and death from
all cardiovascular causes ranges between 25-40% risk reduction (Goldberg et al, 2001).
Red wine contains the polyphenol resveratrol (as do peanuts and red grapes), an
antioxidant which is inhibitory for lipoprotein oxidation (Harvey et al., 2005). Goldberg
et al. (2001) reported that light drinkers of wine cut by one-third their risk of premature
death, and that wine drinkers in general had lower mortality from cardiovascular disease
and cancer.
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In contrast, excessive use of three drinks or more has been shown to increase
incidence of stroke and CHD (O’Connor, Rusyniak, & Bruno, 2005). Unfortunately,
alcohol is highly addictive for some people, and subject to abuse. There are 14 million
Americans that meet the standard criteria for alcohol abuse (Harvard School of Public
Health, 2006). Alcohol can affect CHD by increasing blood pressure and causing
cardiomyopathy. However, even moderate drinking carries risks such as disrupted sleep
and clouded judgment and most physicians will not recommend alcohol for someone who
is not already drinking (Harvard School of Public Health, 2006). Those who drink no
alcohol at all do not have the benefit of alcohol’s positive effects, but they also do not
suffer from any of the negative effects of alcohol abuse. Moreover, there are safer ways
to improve coronary health.
9. Fibrinogen
Fibrinogen, a precursor of fibrin, is a protein globulin which occurs in the blood.
Fibrinogen is an acute phase reactant resulting from injury, and it influences blood
coagulation, therefore relating fibrinogen to both inflammation and thrombosis in the
atherosclerotic process (Kullo & Ballantyne, 2005). Fibrinogen increases plasma
viscosity and increases platelet aggregability (Kullo & Ballantyne). There are several
possible mechanisms by which fibrogen may promote atherosclerosis. These include
filtration into arterial walls with binding to LDL-cholesterol and clotting factors,
promotion of smooth muscle cells, and cholesterol loading of macrophages (Smith, Keen,
Grant, & Sitrk, 1990).
Plasma fibrinogen levels are determined by many things, including genetics, and
are associated with increased adiposity, diabetes, increased age and menopause.
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Smoking leads to increased plasma fibrinogen levels and the effect is dose related, though
it is also reversible with smoking cessation (Kullo & Ballantyne, 2005). Generally
African Americans have a higher fibrinogen level than Caucasians (Folsom, 1992).
Levels above 2.77 g/L are linked to increased CVD (Ma, et al., 1999). Elevated
fibrinogen levels appear to work in concert with high LDL-C, smoking, and hypertension
to further increase risk of cardiovascular events (Kullo & Ballantyne, 2005).
Fibrinogen is less likely to be influenced by minor inflammatory stimuli, and
more likely, compared to CRP, to be a specific marker of atherosclerosis. However, there
is a lack of standardization in assays and cut-off points. This has limited the use of
fibrinogen as a CHD risk predictor (Kullo & Ballantyne, 2005).
F. Additional Risk Factors
At the time of the original ARIC study, the importance of some risk factors
commonly used today was not yet recognized. Among these are CRP and homocysteine.
These, therefore, could not be included in any subsequent analysis although we discuss
them below to present a more complete picture of risk factors that promote
atherosclerosis.
1. C-Reactive Protein (CRP)
CRP is an acute phase reactant in the bloodstream which increases 100 times or
more in response to severe infection, injury or inflammation (Ridker & Cook, 2004). As
such, CRP is a marker of inflammation in the body. Lower blood levels of CRP may not
indicate infection, but do indicate an inflammatory process. High sensitivity or hs-CRP
testing has been developed in this century to particularly identify the low grade vascular
inflammation of atherosclerosis. At least 19 different large scale studies have shown that
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lower levels of CRP as determined by hsCRP testing, even in apparently healthy people,
may be an independent predictor of future vascular events (Zubrod & Holman, 2004).
CRP may actually contribute to the pathogenesis of the atherosclerotic lesion (Pai, et al.,
2004). As atherosclerotic changes begin to take place in the artery, pro-inflammatory
substances including cytokines, are released from surrounding tissues, including fat tissue
adipocytes and damaged arterial walls. CRP is then released from the liver and the
arterial wall, indicating the level of inflammation as well as perpetuating it (Nash, 2005).
There is uncertainty about the role CRP plays in CVD. A 2005 study by Makita,
Nakamura, and Hiramori shows that for both men and women, CRP and early
atherosclerotic changes as shown by carotid IMT were closely associated. However,
when adjusted for age and other traditional risk factors, this association held only for
men. This study indicated CRP might best serve as a complementary and quantitative
marker for atherosclerosis for men, but not for women (Makita, Nakamura, & Hiramori,
2005). Another study (Pai et al., 2004) showed a significant relationship of IL-6 and
CRP to the increased risk of coronary heart disease. A study by Jialal, Devaraj, and
Singh (2006) reached the conclusion that the role for CRP in atherothrombosis is
becoming increasingly supported by emerging data.
2. Homocysteine
A homocysteine is an amino acid whose metabolism is affected by folate,
vitamins B6 and B12, and is associated with increased vascular disease, including
ischemic heart disease and stroke (Harvey et al., 2005). Homocysteine levels are higher
in smokers, those with hypertension, and high total cholesterol levels (Zubrod & Holman,
2004). Lowering homocysteine improves endothelial function (Homocysteine Studies
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Collaboration, 2002). A 1998 study (Voutilainen, Alfthan, Nyyssonen, Salonen, &
Salonen, 1998) demonstrated that with asymptomatic men, the mean IMT of the common
carotid arteries was 1.12 millimeters for men with a high total homocysteine, as
compared to 1.02 millimeters for men with a plasma total homocysteine of less than 11.5
micromols/L (p=0.029). The authors concluded that elevated plasma total homocysteine
is associated with early atherosclerosis. There are several meta-analyses showing lowered
homocysteine levels reduce risk of ischemic heart disease and stroke; however, no
random controlled trials (RCTs) show lower homocysteine levels to reduce the risk of
myocardial infarction, stroke, or mortality (Zubrod & Holman, 2004).
G. Risk Factor Summary
These are a variety of physiologic states or behavior patterns that increase the risk
of developing CVD, and are significant enough to be considered risk factors for CVD
within the parameters discussed. Atherosclerosis is a disease process that begins as early
as en utero (Palinski & Napoli, 2002), and progresses subclinically for many years before
clinical manifestation. The Edinburgh Artery Study (Allan, Mowbray, Lee, & Fowkes,
1997) found atherosclerosis, as measured by mean carotid intimal medial thickening
(IMT), progresses approximately 0.04 mm per decade, or about .004 mm per year.
Greenland et al. (2000) stated that the average annual IMT progression rates are less than
.03 mm. Ambinbakhsh and Mancini (1999) found a progression rate of the far-wall
common carotid artery IMT of 0.034 mm per year or greater to increase significantly the
risk of further cardiovascular events. Many studies, including the Monitored
Atherosclerosis Regression Study (MARS) (Markus, Mack, Aizen, & Hodis, 1997) and
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the Framingham Study (2006), have found that risk factors for CVD and CHD affect the
magnitude of IMT progression.
H. Significance of IMT to Preventive Care
IMT testing permits quantification of pre-clinical atherosclerosis and is therefore
predictive of a CHD event before there is progression of the disease sufficient to cause
clinical manifestation (O’Leary & Polak, 2002). A 1999 study of men 30-50 years of age
(Vrtovev, Keger, Gadzijev, Bardorfer, & Keber) demonstrated that those who had
suffered a myocardial infarction had significantly greater carotid IMT (p=.0001) as
compared to a control group of age-matched men who did not have coronary disease.
Aminbakhsh and Mancini (1999) calculated that once IMT reached >0.822 mm there is
an increased risk of myocardial infarction. By knowing a patient’s personal level of risk,
prior to a CHD event, a preventive care specialist is alerted and can inform a patient
regarding risks and any impending danger well before a CHD event. This affords
significant preventive care guidance for a patient. Appropriate interventions in lifestyle
and/or medication as necessary may then be employed to avoid a CHD event.
Additionally, and at least as importantly, the individual receiving the EMT testing
is made aware of the real, internal damage of their arteries as represented by carotid
artery IMT scan. A visualization of their arteries via the ultrasound imaging scan as well
as the associated computer graphics showing level of risk may well be the most powerful
force in motivating patients to accept guidance and treatment recommended by their
preventive care specialist, including lifestyle changes (Greenland, 2003).
IMT three-site testing exactly as performed by the ARIC Study is not a commonly
performed clinical test, in large part because of the difficulty in accurately acquiring
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measurements for all three sites (Riley, 2002). The hope is that if the test is easier to
perform, more physicians will offer it to patients (Riley, 2002). The common carotid
artery is the most accessible for scanning and is generally easier to test (Howard et ah,
1993; Del Sol et ah, 2002). Reproducibility of IMT measurements is shown in many
studies to be better when limited to the common carotid artery than in studies including
the internal carotid artery and the bifurcation of the carotid artery (Poredos, 2004). In the
time following validation of the three-site testing (Chambless et ah, 1997), physicians
and researchers have, in many cases, chosen to measure just the common carotid artery
(Redberg et ah, 2003). Despite the Rotterdam Study (del Sol et ah, 2002), which
concluded that predictive values were similar for the mean of the maximum IMT for each
of the three measures separately and for the combined three measures, considerable
questions remain regarding whether or not the incremental predictability from this single
site test is indeed statistically valid. This study will answer that question. Upon
validation, single-site scanning may consequently become more widely performed. As
more testing is performed, more individuals and their health care providers will be given
the option to acquire this information, which is predictive of a CVD event. As patients
are able to access this information about how their body is functioning and about their
level of future risk of cardiovascular events, they will be able to make more refined and
appropriate health care choices to prevent coronary heart disease events.
Conversely, if single-site common carotid mean IMT alone is shown to lack
sufficient sensitivity, other multiple-site, simplified modifications in scanning protocols
may be appropriately advocated.
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CHAPTER 2 - LITERATURE REVIEW
A. Overview
In this literature review, I present current literature regarding awareness of
atherosclerosis in cardiovascular heart disease (CVD) in both the medical and lay
communities. I briefly review the history and mechanism of intimal medial thickening
(IMT) ultrasound scanning. I then discuss what the literature shows regarding IMT
scanning of the carotid arteries as a useful tool to assess cardiovascular disease in the
human circulatory system as represented by disease in the carotid arteries, and to predict
CVD event. I look at studies which assess the relationship between IMT and considered
risk factors associated with cardiovascular disease. Finally, in this review the
Arteriosclerosis Risk in Communities (ARIC) Study will be described and the data from
the ARIC Study utilized to determine comparable predictive accuracy of one-site versus
three-site scanning in association with CVD events. The ARIC database will also be
used to assess the ability of both the incremental one-site and the three-site IMT to
predict CVD, both with and without adjusting for selected risk factors.
B. Atherosclerotic and Cardiovascular Disease Awareness
Atherosclerosis is responsible for almost all cardiovascular disease (CVD) and
events including myocardial infarctions (Mis), and cerebrovascular accidents (CVA) or
strokes. These cardiovascular conditions cause the deaths of half of all Americans (Ewy,
2004). Atherosclerosis is a condition which can begin as early as en utero (Palinski &
Napoli, 2002), and advanced and obstructive lesions have been shown in autopsies of
young, robust and asymptomatic individuals (McNamara, Molot, Stremple, & Cutting,
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1971). In 1953, U.S. Army pathologists published a landmark article describing a high
frequency of advanced atherosclerosis in the coronary arteries of Americans who were
Korean War casualties, with an average age of 22 years (McNamara et al, 1971; McGill
& McMahan, 2003). This was one of the first facts which alerted the American public to
the possibility of atherosclerosis existing in young and apparently healthy adults.
Pathological results have been found in many clinical and epidemiologic studies since
then. Schulte-Altedomeburg et al. (2001) demonstrated, in a study of critically ill
patients, that in vivo B-mode ultrasound was a reliable representation of an in vivo
common carotid artery cross-section, as compared to post-mortem study.
The Framingham Health Study, initiated by the U.S. Public Health Service in
1948, was and continues to be conducted by the National Heart Institute, now the
National Heart, Lung and Blood Institute (Framingham, 2006). Its purpose was to
examine heart disease and its possible causes, and these studies eventually highlighted
atherosclerotic involvement in CVD. Results indicating the relationship of blood
pressure, electrocardiogram abnormalities, and cholesterol to increased risk of CVD were
not published until 1961. Remarkably, before Framingham, most physicians believed that
atherosclerosis was an inevitable part of the aging process. Physicians were reportedly
taught that blood pressure should increase with age to enable the heart to pump through
an elderly person’s narrowed arteries (Framingham, 2006). Prior to this time it seemed
incredible that lifestyle choices of the young could promote a disease with deadly
consequences by middle age. As the Framingham Study authors disseminated the new
paradigm they uncovered, they facilitated a change in the way physicians and patients
looked at their lifestyle choices.
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Each of us lives with an arterial evolution going on in our bodies, in some cases
with atherosclerosis beginning while we are in the womb (Palinski & Napoli, 2002).
While 65 million Americans have atherosclerosis, nearly 40% of these people are
unaware that they have it (Ewy, 2004). Each year, of those who have heart attacks,
nearly half (over 650,000 in the US alone) were unaware of their cardiovascular
vulnerability according to the Association for Eradication of Heart Attack (AEHA, 2005),
and over 220,000 of those experiencing a heart attack die within the hour (AEHA, 2005).
The AEHA has coined the term, “the Vulnerable Patient” for these individuals who are at
great risk prior to incident, but totally unaware of the disease process progressing within
them (AEHA, 2005).
Today, evidence of disease in youth is even more alarming. Many teenagers are
not remaining in a preclinical atherosclerotic state, but are instead being diagnosed with
hypertension, a potential clinical consequence of atherosclerosis (McGill & McMahan,
2003). Cross-sectional autopsy studies, long-term cohort studies, and current
development in clinical medicine indicate that risk factors begin to matter in adolescence
(Raitakari et al., 2003). This is the age range during which fatty streaks begin to be
converted to raised lesions and when high risk populations begin to diverge from low risk
populations (McGill & McMahan, 2003). The process continues into adulthood,
progressing to clinical manifestations such as hypertension, peripheral vascular disease,
myocardial infarctions, and strokes. Raitakari et al. (2003), demonstrated that the risk
factor profile in 12-18 year olds was actually predictive of adult common carotid artery
intimal-medial thickening (IMT), independent of contemporaneous risk factors.
Furthermore, there is a strong and graded relationship between carotid IMT and coronary
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heart disease incidence in the Atherosclerosis Risk in Community (ARIC) Study
(Chambless et al, 2002).
A major finding from the Framingham study, however, was that atherosclerosis is
modifiable, not inevitable. It was found that although the risk factors allow and
encourage the progression of atherosclerosis, individuals who avoid these risk factors as
much as possible reduce their chances of acquiring and perpetuating atherosclerosis
(Framingham, 2006). Wilson, D’Agostino, Levy, Belanger, Silbershatz and Kannel, et
al. (1998), in a study from the Framingham Heart Study, formulated a sex-specific
equation to predict CHD risk according to age, diabetes, smoking, categories of blood
pressure from the Joint National Committee 7 (JNC-7) (Chobanian, Bakris, Black &
Cushman, 2003), and the National Cholesterol Education Program (NCEP, 2001) total
cholesterol and LDL cholesterol categories. An example of a relationship of a risk factor
to CVD event risk is that excess body weight is associated strongly and independently to
heart failure risk (NHBLI, 2002). An overweight person has a 34% higher risk for heart
failure compared to a normal weight counterpart. If one is obese, the risk is 104% higher
for heart failure (NHLBI, 2002). While lifestyle significantly influences the severity of
atherosclerosis, and therefore risk of a cardiovascular event, these behaviors are within
our control to positively influence health destiny.
C. Atherosclerotic and Cardiovascular Disease Association with Carotid
Intimal-Medial Thickening as Measured by IMT Ultrasound Scanning
Atherosclerosis is a primary causative factor of CVD, and early diagnosis is
critical to encourage treatment to prevent further progression of the disease. Ideally, the
disease can be detected in a pre-clinical phase (Mancini, Dahlof, & Dies, 2004).
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Previously invasive procedures, including pathologic and angiographic studies, were
utilized to assess health of arteries with the incumbent risks of any invasive procedure.
The current gold standard technique for assessing stenosis of the potential arterial luminal
opening, the opening in the artery for blood flow, and presence of diffuse and focal
plaque in the coronary arteries is the Intravascular Ultrasound (IVUS) (Fritz, Jutzy,
Banal, & Housten-Feenstra, 2005). Intima-media thickening (IMT) imaging is a noninvasive form of the IVUS procedure. The measurement of the carotid arteries by
ultrasound is a simple, non-invasive test that provides information regarding early plaque
deposition and intima-media wall thickening in the carotid arteries (McGill & McMahan,
2003) and was explored as early as 1986 (Pignoli, Tremoli, Poli, Roeste & Paoletti.,
1986). Using ultrasound IMT, one is able to monitor changes in IMT over time (Hodis et
al., 1998) with annual IMT progression rates shown to average < 0.03 mm per year
(Greenland et al., 2000).
Intimal medial thickening (IMT) ultrasound screening has an interesting history in
arterial health analysis. Since the early-1970s, Doppler ultrasound scanning was utilized
to measure blood flow velocity and changes in blood flow. This testing was, and
appropriately continues to be, done primarily in cases where signs or symptoms of
reduced blood flow is suspected. However, Doppler blood flow quantification of arterial
disease is not able to subcategorize lesions of less than 50% stenosis, although more than
70% of CHD events are known to develop in arteries that are less than 50% stenotic
(Crouse, 2001). Interest in detailed IMT measurement of the structural visible portion of
the arterial wall as opposed to only measuring variables of blood flow, came with the
desire to safely look more carefully at the arterial wall itself, and to quantitatively
33

subcategorize lesser degrees of arterial pathology in which the majority of events occur.
Though there are more precise invasive ways to do so, the IMT ultrasound scan has the
ability to take non-invasive and direct, diffuse and focal measurement of the visible
arterial wall. An initial study was done in the mid-80s (Pignoli et ah, 1986) with en vitro
specimens of the human aortic and common carotid arteries, as well as en vivo
measurement with IMT scanning technique of the common carotid arteries of a small
sample of 10 young healthy men (Pignoli et al., 1986). This early study showed the
pathologic level of disease to be correlated with the thickness of different combinations
of layers, each layer with its own thickness, by both gross and microscopic examination
(Pignoli et ah, 1986). The authors concluded that pathologic measures of intimal medial
thickness did not differ significantly from B mode ultrasound scanning results (Pignoli et
ah, 1986).
Since these early in vitro discoveries, studies have been performed with large
population groups to assess the association of carotid artery IMT and CHD event rate
(Heiss et ah, 1991). Both ARIC and the Kuopio studies (Salonen & Salonen, 1991)
found clear associations between diffuse thickening of the arterial wall (IMT) and
presence of focal lesion in the carotid artery, that were previously highlighted as most
predictive and problematic in CHD. These two studies, as well as the Cardiovascular
Health Study (CHS; O’Leary et ah, 1996), additionally showed that those with greater
IMT values had a higher number of cardiovascular risk factors.
IMT measures have since become utilized as an overall measure of subclinical
cardiovascular disease (Poredos, 2004). In a study by O’Leary et ah (1999), of 5,858
participants showed incremental scaling effect of increasing IMT, so that increased risk
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was directly associated with increased thickness of the internal carotid artery, the
common carotid artery, and these two combined. The predictive power of IMT for a CV
event, including MI and stroke, has also been shown (Chambless et ah, 1997; Hodis et
ah, 1998).
Atherosclerosis is a disease of the arterial wall, and carotid ultrasound provides
direct images of the artery wall instead of the lumen, as angiography does (Lonn, 2001).
The “positive remodeling” that occurs in the coronary artery, by which lumen size is
maintained via compensatory expansion of the artery to accommodate atherosclerotic
changes, allows for these disease changes to be undetectable by angiography until they
are quite advanced (Crouse, 2001). These same compensatory changes occur in the
carotid artery (Crouse, 2001). Carotid artherosclerosis and coronary and peripheral
atherosclerosis are commonly found in association with each other (Mancini, Dahlof, &
Diez, 2004). However, early atherosclerosis, as the first measurable morphological
alteration of the arterial wall in CHD and CVD, can be seen with IMT scanning (O’Leary
& Polak, 2002). The presence of plaque and/or increased IMT in an asymptomatic
individual is indicative of preclinical atherosclerosis and these early changes can
typically be seen before clinical manifestations occur (Poredos, 2004).
There is a strong correlation between carotid intimal-medial thickening and
severity of coronary atherosclerosis (Grundy, 1999). In the CHS which included
asymptomatic patients over 65 years of age, the relative risk for MI or stroke increased
linearly with IMT (O’Leary et al., 1999). O’Leary et al. (1999) found IMT to be a
predictive marker for both MI and CVA, with those in the highest quintile having a
relative risk of 3.9 when compared to those in the lowest quintile (p<0.001). IMT
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measurements make it possible to follow progressive damage to blood vessel walls in
individuals (Crouse, 2001). The authors of the ARIC Study concluded that utilizing the
three-site mean carotid IMT, in particular, is a non-invasive predictor of future CHD
incidence (Chambless et ah, 1997).
D. Atherosclerosis and Coronary Heart Disease Risk Factors in Relationship to
Carotid IMT as Measured by Carotid IMT Ultrasound Scanning
Risk factors are defined for a particular disease as an individual’s actions or
characteristics that medical research has shown to be associated with that disease
(Nieman, 1999). There are many risk factors now known to affect cardiovascular health
and therefore carotid IMT findings (Grundy et ah, 1999). Blood lipid levels, including
high levels of total serum cholesterol (TSC), low levels of high-density lipoprotein
cholesterol (HDL-C), high levels of low density lipoprotein cholesterol (LDL-C), and
high triglyceride levels have a strong impact on carotid EMT. Hypertension, obesity,
body mass index (BMI), and diabetes are strongly reflected in carotid IMT. Cigarette
smoking and cigarette pack-years, low physical activity level (Baecke, Burema &
Firjters, 1982), more than moderate alcohol consumption, and high fibrinogen levels are
also reflected in carotid IMT (Grundy et ah, 1998; Grundy, 1999). At the time of
initiation of their study in 1987, the ARIC Investigators chose these risk factors, among
others, because they expected them to be associated with atherosclerosis, and wanted to
explore that relationship. The basic mechanisms of these risk factors were explained in
Chapter 1 with supporting references. These risk factors form the cardiovascular risk
profile for an individual (Oren et al., 2003). The findings of the 2002 Bogalusa Heart
Study (Urbina et al., 2002) demonstrated that as the number of risk factors increases, both
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the common carotid and the bifurcation IMT correspondingly and significantly increases
(p<0.0001). The Cardiovascular Risk in Young Finns Study (Raitakari et ah, 2003)
showed that adult common carotid artery IMT could be predicted by the risk factor
profile assessed in adolescents 12-18 years old, independently of contemporaneous risk
factors. The suggestion made in the Young Finns Study (Raitakari et ah, 2003) is that
choices made for risk factor exposure early in life may induce changes in the arteries that
are conducive to atherosclerosis development later in life.
Following is a discussion of prominent research studies that show association
between these risk factors and atherogenesis and carotid intimal medial thickening. A
cardiovascular risk factor profile that is unfavorable for cardiovascular disease is
associated with a notable increase in common carotid IMT for young adults (Oren et ah,
2003).

1. Lipoprotein Cholesterol Levels
The Monitored Atherosclerosis Regression Study (MARS) (Markus, Mack, Azen,
& Hodis, 1997) showed total cholesterol to be significantly predictive of the annual
progression of carotid IMT (p<0.05). Total cholesterol levels are due in part to
consumption of animal products that contain cholesterol, but are also increased due to the
endogenous production of cholesterol. Cholesterol is a complex molecule, produced by
normal metabolism. It is an important component of cell membranes, is a component of
neural tissue, and is a precursor of Vitamin D and several other hormones. However,
most Americans consume diets that are excessively high in animal fat, and therefore
experience high total serum cholesterol, which has been shown to be associated with
increased carotid IMT (Swan, Bimie, Inglis, Connell, & Hillis, 2003). Wendelhag,
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Wiklund and Wikstrand (1993) found study participants to have carotid IMTs
significantly correlated with increased total cholesterol (rO.47, pO.OOl). Interestingly,
for participants in the MARS study (Markus et al.) increased ratio of monounsaturated fat
relative to saturated fat and stearic acid consumption were significant predictors of annual
IMT progression reduction.
Although total serum cholesterol is a clinically useful tool for informing patients
of dyslipidemia, it is more precise to discriminate between lipoproteins in terms of their
cholesterol densities (Whitney, Cataldo, & Rolfes, 2002). Cholesterol travels through the
body in protein “packages” and these molecules are called lipoproteins. Depending upon
the proportion of cholesterol, trigycerides and proteins within these molecules, they are
identified as low-density lipoproteins, high-density lipoproteins, or a gradation in
between. The higher the cholesterol concentration, the higher density the molecule is
(Harvey et al., 2005). These high density lipoprotein-cholesterol packages contain low
amounts of triglycerides. The inverse relationship exists for low density lipoproteins. It
is the low-density lipoprotein cholesterol (LDL-C) packages that are harmful, and highdensity lipoproteins which perform beneficial functions.
Excess cholesterol, in particular low-density lipoprotein cholesterol, permeates
arterial endothelium in greater amounts than can be eradicated. When excess LDL is
oxidized in the endothelium, atherosclerosis is promoted (Poredos, 2004). This is
because these oxidized LDL-cholesterol molecules are seen by the immune system as
foreign invaders, and are therefore attacked by macrophages. These LDL-laden
macrophages then form foam cells, and it is these foam cells that become the arterial
plaque of atherosclerosis within the intima-media (Wheaton & Pinkstaff, 2006). Low
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density lipoprotein particles are therefore associated with carotid IMT (Liu et ah, 2002).
Wendelhag, Wiklund, and Wikstrand (1993) found that among study participants LDL
cholesterol was significantly correlated to carotid IMT (r=0.33, pO.OOl).
In contrast, HDL-C has an inverse relationship with CHD risk and is protective of
cardiovascular health (Grundy et ah, 1999). In the process of reverse transport, HDL-C
collects excess LDL from the arterial intimal-medial space, and transports it away from
the arteries and into the liver. HDL can also carry antioxidants through the arteries which
can reduce the oxidation of LDL-C, preventing development of a foam cell. With
retarded foam cell production, less atherosclerosis develops. Low HDL cholesterol
concentrations are therefore associated with increased carotid artery intimal-medial
thickening independent of other risk factors in healthy affected members of low HDL
families (Alagona et ah, 2003).
2. Triglyceride Levels
Triglycerides are the predominant form of both storage and dietary fat (Whitney,
Cataldo, & Rolfes, 2002). Hypertriglyceridemia has a demonstrated association with
CHD (Framingham, 2006; Iso et al., 2001). Accurate and consistent triglyceride
measurements are elusive (Garber & Avins, 1994). The role of triglycerides in carotid
artery atherosclerosis is controversial, and in one recent study was found to have no
appreciable role in early onset of common carotid artery IMT change (Magyar et al.,
2004).

Hypertriglycedemia can be a result of hyperglycemia which occurs with diabetes.
In a recent study (Dharmalingam, Despande, & Vidyasagar, 2004) of well-controlled
diabetics, the post-prandial and fasting triglyceride levels were measured. These levels
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were found to have a significant correlation. Researchers found an association of fasting
triglycerides to carotid intimal medial thickening, but this association was not as clear-cut
with postprandial triglycerides. The authors suggested that fasting triglyceride level, the
more homeostatic level, might be substituted for postprandial triglycerides to increase
accuracy as a marker for early atherosclerosis. Another study (Teno et al., 2000), states
that postprandial triglycerides are elevated for 3-6 hours after a meal and exacerbated
with the next meal, leaving humans in a postprandial state of elevated triglycerides most
of every twenty-four hours. Finally, Davis, Dawon, Riley, and Lauer (2001) found that
triglycerides were predictive of increased carotid IMT in women, but not in men. There
remains a question as to the legitimacy of triglycerides as an indicator for carotid IMT.
3. Hypertension
Hypertension is defined as systolic blood pressure greater than or equal to 140
mmHg and/or diastolic greater than or equal to 90 mmHg as established by the Seventh
Joint National Commission (JNC-7; Chobanian, Bakris, Black, & Cushman, 2003).
Hypertension is a strong risk factor for CHD (Wilson et al.,1998). Hypertension is
positively associated with carotid IMT through mechanisms such as reduced
endothelium-dependent vasodilation, suggesting that hypertension induced endothelial
dysfunction might be involved in the early stages of atherosclerotic artery changes
(Ghiadoni et al., 1998). Additionally, one of the primary results of higher hemodynamic
arterial flow resulting from hypertension is microtears to the endothelial layer
(Eckardstein von, Hersgerger, & Rohrer, 2005). These microtear injuries instigate the
inflammatory cascade which is critical to the atherogenic process. Higher blood pressure
and the higher rate of blood pressure fluctuations, which are greater in patients with
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hypertension, correlate to increased IMT of the common carotid arteries (Zakopoulos et
ah, 2005).
A statement from the National Heart, Lung and Blood Institute (NHLBI) (1998)
suggested that hypertension and atherosclerosis have a synergistic relationship with many
interactions of vascular processes. Pauletto et ah (1999) found that borderline
hypertensives had 1.2% raised atherosclerotic lesions compared to 0.3% in the control
group. Further, they concluded that even in borderline hypertension, a definite role of
blood pressure levels exists in determining carotid artery IMT.
4. Body Mass Index and Obesity
Body mass index (BMI) is a function of weight in relation to height via the
mathematical equation weight in kilograms divided by height in meters squared (Dalton,
1997) The greater the body weight, the larger the BMI. Body mass index is used as an
indicator of weight status, including obesity; 20-24..99 being normal, 25-29.99
overweight, and 30 and over, obese. Obesity results in a two- to six-fold increase in the
risk of developing hypertension, with the risk increasing in a step-wise fashion with
increased body weight (Witteman, 1989), and similarly hypertension is associated with
increased IMT. Obese adolescents, with body mass index > 95th percentile for age and
sex, had a thicker mean IMT of the internal carotid arteries than non-obese adolescents
(Stabouli, Kotsis, Papamichael, Constantopoulos & Zakooulos, 2005). A recent study
(Balletshoffer & Rettig, 2005) showed a significant correlation between BMI and
increased carotid IMT (r=0.358, p=0.001), and this association was correlated to
adiposity-related inflammation as measured by hs-CRP, rather than insulin sensitivity. In

41

the MARS study, BMI was significantly associated, along with cholesterol and smoking,
with annual progression of carotid IMT (Markus et al., 1997).
5. Diabetes
Diabetes is strongly associated with increased carotid IMT. In a recent study
(Penckofer, Filliung & Labropoulos) the mean carotid IMT was .88 mm for women with
type 2 diabetes compared with .74 mm for women without type 2 diabetes, with 10% of
the women in this study requiring surgical intervention for arterial stenosis. The Insulin
Resistance Atherosclerosis Study (IRAS) showed that insulin resistance and diabetes
accelerate carotid EMT (Wagenknecht et al., 2003) and that there is a progressive increase
in IMT with progression of diabetic symptoms. In support of these conclusions, another
study found a positive association of increased carotid EMT with impaired glucose
tolerance, and additionally found diagnosed type 2 diabetes associated with a more
significant increase in carotid EMT (Poredos et al., 1999). For established diabetes,
progression of carotid IMT was 0.896, and decreased for newly diagnosed diabetics
(0.831), persons with impaired glucose tolerance (0.822), and persons with normal
glucose tolerance (0.802) (Poredos et al., 1986). Accelerated annual progression of
carotid IMT is highly associated with diabetes (Markus et al., 1997). Yamasaki et al.
(2000) found the annual progression of carotid IMT in diabetics to be 0.04 ± 0.004
mm/year, in contrast to a study by Ando, Takekuma, Mino and Shimokata (2000) which
found non-diabetic carotid IMT progression to be 0.004 mm/decade. These two studies
suggest that diabetics have 10 times the progression of carotid artery IMT than their non
diabetic counterparts. The duration of diabetes is also strongly related to increased carotid
IMT (Taniwaki et al., 1999).
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Blood glucose interacts with other mechanisms in the body, such as blood
pressure. In a 2004 study, Tropeano, Boutouyrie, Katsahian, Lalous and Laurent found
that in patients with hypertension and hyperglycemia, glucose level is a major
determinant of carotid IMT. The connection between diabetes and hypertension is further
elucidated in another 2004 study (Leinonen et al., 2004), which found that the major
determinants of IMT in the diabetic were diabetes duration and blood pressure.
6. Smoking
Smoking is an important modifiable risk factor for cardiovascular disease
(Grundy et al., 1998), and significantly associated with annual progression of carotid
IMT (Markus et al, 1997). The rate of CVD is 67% higher in those currently smoking
(Wattanakit et al., 2005). Increases in carotid IMT are directly related to the duration of
smoking and number of cigarettes smoked (Poredos et al., 1999). These researchers
found the greatest carotid EMT in active smokers (0.807 ± 0.009). Suga et al. (1997)
found a significant correlation between mean carotid IMT and smoking. In their study,
there was a significant association of never, current, and former smoker status with both
carotid and femoral IMT. A study by Gariepy et al. (2000) found a correlation for men
of IMT to current daily smoking (p<0.01) and lifelong smoking (pO.001,) further
indicating a smoking-related increase in IMT.
7. Sports Activity Level
Physical activity has a well-known inverse relationship to atherosclerosis and
CHD (Poredos, 2004; Abramson & Vaccarino, 2002; Smith, 2001). Various athletic
activities, such as stair-climbing, have been linked with reduced carotid atherosclerosis
(La Monte, 2004). Exercise training may stop or reverse atherosclerosis by inducing
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atheroprotective phenotypes in endothelial and T cells (Smith, 2001). Lakka et al. (2002)
showed that good cardiovascular fitness is associated with slower progression of
atherosclerosis. It is by virtue of its relationship to atherosclerosis and inflammation that
physical activity is primarily linked to lower carotid IMT (Lakka, et al., 2001; Abramson
& Vaccarino, 2002). In a four year study of 854 men ages 42 to 60, good
cardiorespiratory fitness was strongly and inversely associated, in a graded manner, with
slower progression of atherosclerosis (f3= -0.120; p=0.002) (Lakka, et al.). Ultrasound
measurement of carotid IMT is regarded as a valid index of atherosclerosis (StenslandBugge, Bonaa, & Joakimsen, 2001). An Italian study by Casiglia, et al. (2000) showed
lack of exercise to be an independent early predictor of carotid wall thickness.
8. Ethanol
Ethanol has shown varying relationship to CHD (Mukamal, Kronmal, Mitleman,
O’Leary, Polak & Cushman, 2003). Alcohol has benefits such as relaxation and general
vasodilation, also reduction of fibrinogen and clotting factor VII, and elevation of HDL
(Harvey et al., 2005). One to six drinks of alcohol per week has an inverse relationship
to carotid IMT, while consumption of 14 or more drinks has a positive association to
carotid IMT (Mukamal et al., 2003). A study of French adults (Zureik et al., 2004),
concluded that neither common carotid artery IMT or carotid plaques were positively
associated with alcohol consumption, although they found that carotid artery diameter
increased. They attributed this to possibly the ability of alcohol to maintain adaptive
arterial enlargement, preserving the lumen.
Another study of French people in 1999 (Ferrieres, Elias, Ruidavets, Cantet,
Bongard & Fauvel) showed that in a low CHD risk population of middle-aged men and
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women, alcohol consumption was positively and significantly associated with increase
carotid IMT. A 2001 study by Kao, Puddey, Boland, Watson and Brancati showed that
high alcohol intake increases diabetes risk among middle-aged men, thereby increasing
likelihood of increased carotid IMT.
Alcohol’s effect on carotid IMT is still controversial. Small amounts of alcohol
appear to cause some cardiovascular benefits, while large amounts clearly cause
progression of atherosclerosis as reflected by carotid IMT. Advisability of drinking
alcohol is, therefore, controversial. There is significant danger of abuse when drinking
alcohol, with 14 million Americans meeting the criteria for alcohol addiction (Harvard
School of Public Health, 2006), so costs may well out-weigh the benefits.
9. Fibrinogen
Fibrinolytic activity is also linked to IMT (Poredos, 2004). Fibrogen is an
independent risk factor for CVD (Folsom, 2001). Fibrogen is an acute phase reactant and
can infiltrate the arterial wall to bind with LDL and with other clotting factors.
Fibrinogen may promote atherosclerosis by a number of possible mechanisms including
filtration into arterial walls and binding with LDL-cholesterol and clotting factors, as well
as promotion of smooth muscle cells, and macrophage loading with cholesterol (Smith,
Keen, Grant, & Sitrk, 1990). Fibrinogen can be a precursor of mural wall thrombi,
arterial plaque that blocks blood flow. Additionally fibrinogen degradation products may
stimulate smooth muscle cell proliferation and cholesterol loading of macrophages
(Smith et al.). When compared to carotid IMT, there was a strong, positive association for
fibrogen to carotid IMT (p<0.01) (Martinez-Vi 11a et al., 2003), independent of
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confounders. A more minimal association (r=0.25) was found between fibrinogen and
carotid IMT by researchers in 2001 (Tanaka, Dinenno, Monahan, DeSouza, & Seals).
E. Risk Factor Summary
As stated by O’Leary et al. (1999), increase in intimal medial thickness of the
carotid artery, as measured by IMT ultrasound scanning, is directly associated with
increased risk of cardiovascular disease event. Additional risk factors elevate this risk by
increasing carotid artery IMT. Wattanakit et al. (2005), in examining the association
between risk factors and carotid IMT, concluded that carotid IMT itself is a CVD risk
factor. Changes in arteries may occur, in part, from the influence of risk factor exposure
early in life, and a risk profile assessed in 12-18 year olds predicts IMT of the common
carotid artery in adulthood (Raitakari et al., 2003). Conversely, Markus et al. in the
MARS (1997) found that modifications of risk factors with lifestyle changes such as
decreasing body mass index by 5 kg/m2, reducing dietary cholesterol intake by 11
mg/day, and quitting a 10 cigarette/day habit slowed progression of carotid EMT by 0.13
mm/year. Thus, it is important to consider these CVD risk factors to see if IMT can
predict CVD beyond the influence of these factors.
F. The Atherosclerosis Risk in Communities (ARIC) Study
The ARIC Study utilized a sample of initially 13,864 asymptomatic male and
female participants, 45-64 years of age, to examine the relationship of mean carotid IMT
with incident CHD, including CHD and MI events. Our study sample was decreased by
excluding all imputed values and only using participants for whom there was raw data. A
second sample was defined by utilizing this non-imputed population, and then excluding
all values <.5 mm. CVD event was defined as CVA or CHD incidence. CVA incidence
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was defined as stroke or transcient ischemic attack (TIA) as diagnosed by a physician.
CHD incidence was defined as definite or probable hospitalized myocardial infarction, a
definite CHD death, or an unrecognized myocardial infarction (discovered as changes at
time of yearly evaluation). This relationship between CVD event and IMT was assessed
over four to seven years of follow-up.
In the course of the ARIC Study, three locations on the carotid artery were used
bilaterally. These three sites were 10 mm long IMT sections each of the bifurcation or
bulb (BIF), the internal carotid (ICA), and common carotid (CCA). To calculate the
carotid mean IMT, 11 ultrasound measurements were taken, evenly spaced, along a
particular 10 mm segment for each of the three sites (BIF, ICA, and CCA) bilaterally,
resulting in 22 measurements for each site when left and right side measurements were
included. Then at each site, the 22 measurements were averaged resulting in three
means, a single mean for each of the three sites. The mean of these three numbers was
then taken. Thus, the mean IMT for the three sites is the mean of 33 measurements
performed bilaterally, equaling 66 measures for each individual.
Subsequent investigators (Chambless et ah, 1997) have found a strong association
between this three-site combined mean measurement and the mean of the 11 CCA
measures of IMT alone (age-adjusted 75th percentiles establish a level of age-adjusted
relative risk) (Redberg et ah, 2003). While the carotid three-site mean IMT has been
shown to have a strong predictive association with CHD (Chambless et ah, 1997), there is
a difference in visualizability for the three different sites with CCA mean IMT being
more consistently visualizable (with 91% for the CCA, 49% for the ICA, and 75% for the
BIF) (Howard et ah, 1993). Additionally, the CCA is easiest to access and to provide a
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recordable ultrasound image (Howard et al., 1993). It is also more easily measurable
than the other carotid sites (Chambless et al., 1997; Howard et al., 1993). Only 13% of
the sample had a visualizable mean IMT at all six sites (Chambless et al., 1997). One of
the segments of the ICA was visible less than 50% of the time (Howard et al., 1993),
resulting in less than reliable or accurate measurement. Thus, alternative methods for
ascertaining accurate and reliable measure of IMT within the carotid arteries must be
explored.
G. Conclusion
Due to the difficulties and impracticalities of three-site carotid artery mean EMT
scanning, it is important to see how well CCA mean IMT alone might be correlated to
CVD events and to selected risk factors. This study will contribute to the documentation
of findings of validity and reliability of one-site mean IMT versus three-site mean IMT
correlations to CVD events utilizing the ARIC database. This study will additionally
document the predictiveness of incremental one-site mean IMT for CVD events, with
adjustment for risk factors. With the possibility of greater ease of execution that would
result from only one-site IMT being necessary for robust prediction of CVD events, it is
hoped that IMT testing will be offered to patients and performed in a more routine
manner.
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CHAPTER 3 - METHOD
A. Study Design Overview
The ARIC Study, conducted from 1987-1996, focused on implementing a
prospective study design utilizing 13,864 participants 45-65 years of age with no history
of cardiovascular events. The participants were to be tracked for CVD status and other
clinical parameters periodically, in the hope of shedding light on the etiology of
atherosclerosis and its clinical presentation. Included participants were initially free of
clinical CVD. IMT measurements were taken at baseline and correlated with clinical
events and clinical parameters that had occurred over the next 6-9 years, at an average of
6.2 years.
This study utilized a prospective observational design; health information was
obtained initially and at the subsequent follow-ups. The data was used to assess of
whether a positive association existed between mean bilateral three-site combined mean
IMT and CVD incidence in asymptomatic individuals between 45-64 years of age.
Particular risk factors were also measured and controlled for.
The purpose of our analysis of the ARIC database was to raise a question from the
previously published analyses of the ARIC Study. The initial ARIC Study evaluated
three sites; the distal centimeter of the common carotid, the carotid bifurcation and the
proximal centimeter of the internal carotid. In subsequent studies, the average mean IMT
at the CCA has been found easier to access, more visualizable (Howard, 1993), and easier
to measure than other commonly measured sites (Chambless et al., 1997). Only 4% of
participants were missing data at both the left and right common carotid mean IMT
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(Chambless et al., 1997). The question reasonably arises whether this one site could be
used alone to determine the risk of CVD. This study was designed to look at this
possibility using only actual ARIC data acquired from participants. Since participants
with missing IMT data were excluded, our sample size was substantially reduced from
the original size.
The first question was to see how the association of the mean CCA IMT to the
CVD incident rate compared with the mean three-site combined EMT values and whether
it was therefore reliably predictive of CVD. This comparison for diagnostic accuracy
was done using Receiver Operator Characteristic (ROC) curves and comparing area
under the curves (AUC). The second question was to determine whether the average
incremental mean CCA site alone had a reliable association to CVD incident rate at five
incremental IMT levels, with and without adjustment for selected risk factors, and also
compared to the average incremental mean three site association to CVD incident rate at
five incremental levels, with and without adjustment for selected risk factors. These
incremental assessments were done for non-imputed data, and for non-imputed data with
values < 0.5 mm excluded. Values with < 0.5 mm are believed to occur in only 1% of
the population. Additionally TCRF were assessed for association with CVD event alone.
Then one-site and three-site IMT were separately assessed for association with CVD
event after these TCRF were controlled for.
B. Study Population
The ARIC Study population consisted of white and black participants from four
geographically diverse United States suburbs: Forsyth County, North Carolina; Jackson,
Mississippi; Minneapolis, Minnesota; and Washington County, Maryland. The
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participants in the cohort group were asymptomatic men and women between 45-64 years
of age at the time of baseline measurements in 1987. Community selection was made to
acquire diversity of mortality and urbanization, with slightly more urban than rural
representation.
Study participation was limited to only black and white persons. Both genders
were included, with results calculated for each sex, and then for both sexes together.
Socio-economic factors of education and annual income were noted, but not controlled
for. Participants were selected from various sources including lists of persons with
driver’s licenses, voter registration cards, and eligibility for jury duty. Home interviews
were then conducted to assess cardiovascular risk factors, socioeconomic status and
family medical history. Participants were then invited to a clinic exam, at which time
blood assays and other physical exams, such as height and weight measurements, were
conducted.
Additionally, there was a surveillance group among community residents who
acted as a control group. Coronary heart events, defined as myocardial infarction
requiring hospitalization and coronary heart disease death, were ascertained for all
residents in the community, 35-74 years of age, as these individuals comprised this
control group. This group was tracked via hospitalization and death record reviews, and
was assessed for CVD events until 1993 (The ARIC Investigators, 1989).
C. Study Variables in the ARIC Study
Baseline variables from the ARIC database include IMT, cardiac event status and
risk factors as cited below. The dependent variables are CVD event status. Independent
variables are IMT and the traditional CVD risk factors (TCRF).
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1. Dependent Variable
CVD event status: a physician diagnosed myocardial infarction, evidence
of prior myocardial infarction by electrocardiogram (ECG), history of
cardiovascular angioplasty or surgery, or CHD death, or a stroke or transcient
ischemic attack (TIA).
2. Independent Variable
a) IMT: the thickening of the layer of cells between the circulatory lumen
and the advential vessel wall. This thickness is determined by B-mode
ultrasound scanning of the carotid artery at one centimeter lengths of three
different carotid artery locations: the internal carotid, bifurcation of the
carotid and common carotid arteries. Eleven measurements were evenly
taken on both right and left sides for each centimeter length, and these
twenty-two values were averaged for a mean carotid artery IMT for that
site.
b) Traditional Cardiac Risk Factors’.
1) Low Density Lipoprotein Cholesterol (TDD: blood serum
values of greater than or equal to 160 mg/dl (yes or no)
2) High Density Lipoprotein Cholesterol (HDD: blood serum

values of less than or equal to 40 mg/dl for men and women (yes
or no)
3) Total Serum Cholesterol (TSC): blood serum values of greater

than or equal to 200 mg/d (yes/no).
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4) Triglycerides: serum blood levels of greater than or equal to 150
mg/dL (yes/no).
5) Hypertension: systolic blood pressure of 140 mmHg or more;
diastolic blood pressure of 90 mmHg or more (taken two times,
10 minutes apart, and averaged) or use of anti-hypertensives as
self-reported.
6) BMI: body weight in kg/height in m2.
7) Obesity: defined as greater than or equal to a 30 BMI.
8) Diabetes: fasting blood serum glucose level of 126 mg/dl or
more, or non-fasting blood glucose level of 200 mg/dl or more
(yes/no).
9) Smoking: current smoker, ex-smoker, or never smoked from
self- report.
10) Cigarette-Years: packs per year of smoking, from self-report,
placed into one of three categories: none, low (1-10 packs/year)
or high (greater than 10 packs/year).
11) Physical Activity: “habitual sports activity” (Baecke, Burema &
Fiijters, 1982) over a seven day period and then repeated three
months later, as per self-report.
12) Ethanol: grams ingested per week as per self-report, placed into
one of three categories: none, low (< 2 ounces/day), moderate
(> 2 ounces/day).
13) Fibrinogen: not available in data set provided.
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Clinical parameters, including cardiovascular events, were tracked yearly. The
IMT scan for this analysis was performed and recorded at baseline only.

D. Data Collection of IMT Values, Risk Factor Values, and CVD Event Rates in the
ARIC Study
IMT ultrasound examinations were conducted by scanning sessions for 45
minutes (Howard, 1993). Four ARIC Field Center Ultrasound Stations were used, one for
each of the four communities sampled. Control panels displayed requirements for the
sonographer during the scanning process. Videotapes of ultrasounds and related data
were stored on the video and audio sections of videocassettes which were then stored on
the computer at the Field Center.
Diagnostic ultrasound scanners were utilized, with the participant supine.
Imaging was performed at three different carotid sites bilaterally. The three sites utilized
were the common carotid artery (CCA), the bifurcation (BIF), and the internal carotid
artery (ICA). The carotid artery is a site that has a predilection for early atherosclerosis
and is sufficiently superficial for accurate ultrasound evaluation (Howard et al., 1993).
The area to be measured in each segment was clearly defined for standardization. The
CCA length was defined as 1 cm proximally from CCA bifurcation. The bifurcation
measurement begins at the initial branching away from the CCA to the flow divider. The
internal carotid was measured from the flow divider 1 cm distally.
For a 1-cm length of each of these arterial segment sites, average and maximal
thickness for the near and far wall were measured. Thickness was measured from the
blood-intimal to the medial adventitial interface. Electronic calipers were used on
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digitized video images and measurements along each 10 mm segment were made at each
millimeter point, with a total of 11 measurements for each of the 1 -cm lengths for both
the right and left side, or 33 on each side. Ultimately, these 66 measurements of 1-cm
lengths of the carotid bifurcation, and internal and common carotid, right and left, were
averaged for the combined three-site mean IMT.
Blood was drawn after a 12 hour fast by venipuncture for assays by specified
hematological laboratories. Processing for the blood required special preservatives,
filtration, and low temperature centrifugation and shipping. Blood was then stored at 70° C in central laboratories. Lipid measurements were made from the blood including
LDL-C levels, HDL-C levels, TSC levels, and triglyceride levels. Lipoproteins were
included because of their importance in the atherosclerotic process. Blood glucose was
also measured. Glucose was measured as an indicator of diabetic status, with prevalent
diabetes mellitus defined as a fasting blood glucose 140mg/dl (updated in this study to
126 mg/dl) or greater or random, non-fasting blood glucose at 200mg/dl or greater.
During interviews, smoking status was ascertained by self-report and recorded as
never having smoked, ex- or current smoker, and by pack-years. Current ethanol
consumption was ascertained by self-report and recorded in grams/week. Clinical exam
items included body mass index [BMI] (kg/m2), and blood pressure measurement. The
definition of prevalent hypertension was systolic blood pressure of 140 mmHg or more,
and diastolic blood pressure of 90 mmHg or more as measured two times, or self-reported
use of anti-hypertensive medication. Also included in clinical exams was a sport activity
index (Baeke, Burema & Friijters, 1982) which asked for activity level at work, leisure
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and “other”, per week. Each of these activity levels was rated to be between one and five
by self report.
CHD at baseline was considered exclusionary and defined as a physiciandiagnosed myocardial infarction, evidence of prior myocardial infarction by
electrocardiogram (ECG), or history of cardiovascular angioplasty or surgery. CHD
event incidence was then monitored on a yearly basis in several ways. CHD incidence
was assessed by contacting participants annually, by identifying hospitalizations and
cardiac related deaths in the previous years, and by acquiring both hospital discharge lists
and death certificates in order to look for cardiovascular events. Risk factors were to be
reassessed after three years; however the mean time for follow up was 6.2 years
(Chambless et al., 1997). Trained abstractors evaluated presenting symptoms and cardiac
enzymes from hospital charts, and photocopied up to three ECGs for each person
suspected of having a cardiovascular event (Chambless et al., 1997).
A CVD incident event was defined as a CHD or CVA event. A CVA event was
defined as a stroke or TIA, as diagnosed by a physician. CHD incident event following
baseline measurement was based upon chest pain symptoms, ECG changes, cardiac
enzymes levels, or death. The event was defined as a validated definite or probable
myocardial infarction, a definite CHD death, or unrecognized myocardial infarction. For
a death to be determined a CHD death, chest pain symptoms, underlying cause of death,
and pertinent hospital information was used. An unrecognized myocardial infarction
incident was determined via two follow-up examination ECGs with comparison to
baseline. A Morbidity and Mortality Classification Committee (Chambless et al., 1997)
reviewed clinical events and determined final diagnoses. One final definition for CHD
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event incidence was considered, and this was with inclusion of CHD-related revascularizations noted on ICD-9 hospital discharge codes. Following examinations of
chest pain symptoms, ECG changes and cardiac enzyme levels, results were reviewed
with participants and a physician or physician assistant. Findings were verified, and any
appropriate referrals for either diagnosis or treatment were made as appropriate.
E. Data Analysis
1.

ARIC Study (Howard et al., 1993)
The investigators in the ARIC Study directly observed the early signs of

atherosclerosis, defined by the association of three-site mean IMT and CHD event rates.
Combinations of ultrasound measurements from all arteries examined were used to index
the participant’s level of atherosclerosis. Analyses included examination of the
associations of atherosclerosis and risk factors that may have impacted atherosclerosis.
Both the risk factors and indicators of pre-clinical disease, in particular IMT as an
indicator of atherosclerosis, were then studied in relation to subsequent CHD events.
.Subsequent measures of independent variables took place at three and six years.
2.

Research Questions and Analyses

Question 1 — How does the one-site mean CCA mean IMTpredict risk of a CVD
event, and how does this result compare to the three-site mean combined mean IMT in
predictivity of CVD event? The area under Receiver Operator Character (ROC) curves
was compared for both the one-site CCA mean IMT and the three-site combined mean
IMT by calculating a critical z ratio for both IMT methods. The z ratio was then
compared to the z of 1.96 at an alpha of 0.05 for significant differences between both
ROC curves. ROC curves were used to describe and compare the performance of the two
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diagnostic modalities. The ROC curve is a plot of true positive versus false positive
results in diagnostic testing depicted graphically with the false positive rate on the X axis
and the true positive rate on the Y axis. Accuracy is measured by the area under the ROC
curve. An area of 1 represents a perfect test; an area of 0.5 represents a test showing no
improvement in diagnostics ability (so if therefore worthless). The point (0,1) is the
perfect classifier: it classifies all positive cases and negative cases correctly. It is (0,1)
because the false positive rate (FP) is 0 (none), and the true positive rate (TP) is 1 (all).
The point (0,0) represents a classifier that predicts all cases to be negative, while the
point (1,1) corresponds to a classifier that predicts every case to be positive. Point (1,0) is
the classifier that is incorrect for all classifications. In many cases, a classifier has a
parameter that can be adjusted to increase TP at the cost of an increased FP or decrease
FP at the cost of a decrease in TP. Each parameter setting provides a {FP, TP) pair and a
series of such pairs can be used to plot an ROC curve. The figure below shows an
example of an ROC graph with two ROC curves relative to curve with an area under the
curve of 0.5 (worthless).
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Figure 1. Receiver Operator Characteristic (ROC)
Curves, comparing results for two diagnostic tests.
The area under the ROC curves was compared for both the one-site IMT and the
three-site IMT by calculating a critical z ratio for both IMT methods. The approach to
assessing whether the area under the two curves derived from the same subjects is
random or real is to calculate a critical z-ratio. The z-ratio of the curves was then
compared to the z of 1.96 at an alpha of 0.05 for significant differences between the ROC
curves. The additional adjustment for clinical and demographic covariates which
could confound the results of IMT on CVD events is unnecessary because the
comparisons investigated are from the same population. True accuracy, displayed by
ROC curves of the 1-site versus the three-site IMT measurements, was compared to
establish whether the OSCMI and TSCMI were equal or different in their diagnostic
ability. A paired comparison of the OSCMI and TSCMI ROC curves was used to
determine the existence of a statistically significant difference (p-value less than 0.05).
59

Question 2 — What are the risks of CVD event for five different incremental levels
of one-site mean common carotid artery average of right and left far-wall IMT, alone and
after adjusting for the potential confounding factors collected in the ARIC Study? How
do these values compare to those offive different incremental levels of three-site mean
common carotid artery average of right and left far-wall IMT, alone and after adjusting
for the potential confounding factors collected in the ARIC Study? A gender stratified
logistic regression was used to compare CVD events for the five different levels of onesite IMT, with and without controlling for potential confounders. This same procedure
was performed for five different levels of three-site IMT, with and without controlling for
potential confounders. Results were compared for both tests. Potential confounding
factors included: TSC, HDL, LDL, triglycerides, glucose, BMI, hypertension, sport
activity index, smoking status, pack years smoked, ethanol consumption, race and age.
Due to the categorical nature of some of these variables, dummy variables were utilized
in the logistic model.
F. Power Analysis
Power is defined by Cone and Foster (1993) as the extent to which the statistics
used can detect the effect of the independent variables (IMT and risk factors) on the
dependent outcome variable (CVD event rate). Adequate power size was provided by the
very large sample size in this project of 13,824 people for the first study, over 12,000 for
the second, and 4,366 for our study, which included only subjects extracted who had all
values, with none less than 0.5 mm. Power calculations for this number of dependent
variables at a conservative R-square increment indicated a minimum sample of
approximately 1,700.
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G. Ethical Concerns
All data analyzed in this study was from a database owned by National Heart,
Blood and Lung Institute (NHBLI), and held by the University of North Carolina. These
records are available for public use with authorization from NHBLI, authorization that
was granted to Dr. Roy Jutzy, the Principle Investigator (PI) for Loma Linda University
Medical Center’s database analysis, and a consultant for this study. All data is deidentified and as such, Dr. Jutzy has been granted exempt status by the Loma Linda
University (LLU) Internal Review Board (IRB) for the use of this dataset. IRB exempt
status was extended by the LLU IRB for the use of the dataset in this study. This was an
observational study, and as such did not in anyway impact the de-identified participants
of the study.
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Predictability of cardiovascular disease event rates by common carotid artery
intima-media thickness sampling in the atherosclerosis risk in communities (ARIC)
Study
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ABSTRACT: Risk prediction functions for incident cardiovascular disease (CVD) were
estimated using data from the Atherosclerosis Risk in Communities (ARIC) Study, a
prospective study of CVD. Data analyses were conducted with ultimately 4,366 persons
recruited in 1987-1989 from four U.S. communities who were measured at baseline and
for 6 year follow-up. Predict!vity of incident CVD was assessed by determining the area
under the receiver-operator characteristic (ROC) curve. Predictivity of CVD by IMT,
with and without adjustment for traditional cardiovascular risk factors (TCRF), was
performed by odds ratios (OR) utilizing one site common carotid artery (CCA) mean
intima-media thickness (IMT) (OSCMI) alone and also three site combined mean IMT
(TSCMI).
Predictivity of CVD event was attenuated when either risk factor adjustment or IMT
adjustment was implemented, but remained significant, confirming the independent
prognostic value of each. A model employing exclusion of CCA mean IMT raw
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measurements of less than 0.500 mm resulted in 50% improved predictivity of TSCMI in
women and 20% in men.
In conclusion, OSCMI and TSCMI are similarly associated with future cardiovascular
events. The intima-media thickness of common carotid artery mean IMT has a practical
advantage over and statistical parity with mean measurements of the two other sites.
Introduction
Cardiovascular disease (CVD) is projected by 2020 to become the leading cause
of death in all developing countries. The first manifestation of one type of CVD, coronary
heart disease (CHD), in about 50% of cases is acute MI or sudden death.1 Early
awareness and treatment of the atherosclerotic disease process before CHD or other CVD
events is therefore critical.
Carotid ultrasound scanning is a non-invasive imaging technique found to be
effective, valid, and reliable in ascertaining extent and severity of atherosclerotic disease
in the carotid arteries2 Measurement of the IMT on brightness-mode ultrasound did not
significantly differ from IMT measured on pathologic examination.

Carotid

atherosclerosis also reflects the severity and extent of atherosclerotic disease in the
coronary and other arteries throughout the body when measured at postmortem
examination (p=0.46 to 0.57).4,5 Carotid atherosclerosis reflects the same degree of
correlation with coronary artery atherosclerosis as the degree of correlation of
atherosclerosis that exists between the right and left coronary arteries.
Carotid IMT is a refined aspect of the standard carotid ultrasound test and IMT is
now increasingly being used to ascertain cardiovascular status in selected asymptomatic
individuals, prior to the development of clinical signs or symptoms of atherosclerosis.6
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Positive atherosclerotic associations utilizing three carotid artery sites have been
validated by numerous investigators.

2,6-8

These three carotid artery sites are the common

carotid artery (CCA), the bifurcation of the carotid artery (BIF), and the internal carotid
artery (ICA). Three-site mean carotid mean LMT has an association with the incident rate
of CHD, one form of CVD. CVD was shown and documented for a large population of
asymptomatic men and women ages 45-65 in the Atherosclerotic Risk in Communities
(ARIC) Study.7 Carotid three-site mean IMT scanning is a safe, inexpensive, precise,
and reproducible measure. 9,10 There are, however, some difficulties associated with the
three-site carotid mean IMT scanning methods, centering around missing data issues.
Visualizability, meaning the percentage of time that satisfactory visibility of a 10
mm. long segment was achieved, was 46% for internal carotid artery, 72% for the
bifurcation and 92% for the common carotid artery.10 As a result of the low visibility of
the bifurcation and especially the internal carotid arteries, researchers in the ARIC Study
chose to impute a substantial percentage of their IMT values to compensate for their
missing data.7 However, common carotid artery mean IMT is more easily visualizable,
imaged, and measured than the other carotid sites, resulting in improved measurement
reliability.10 It may facilitate utilization of carotid IMT ultrasound scanning for
determination of atherosclerotic disease severity if it were only required to access onesite measurement of CCA IMT for CVD predictive value especially if it was equivalently
or even superiorly robust to the three site measurementsv It has not been documented
how the incremental CCA mean one-site IMT event rates correlate to three-site
incremental mean combined mean IMT event rates and this study provides that
documentation. In addition, we also provide documented evidence of the relationship of
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one-site incremental CCA mean IMT to CVD incident rate with and without adjustment
for selected risk factors and three-site incremental IMT to CVD incident rate with and
without adjustment for selected risk factors.
Methods
The ARIC Study conducted from 1987-1993 focused on implementing a prospective
study design utilizing 13,864 participants 45-65 years of age with no history of
cardiovascular events. The participants were tracked for CVD status and other clinical
parameters periodically, on average 6.5 years, with the hope of shedding light on the
etiology of atherosclerosis and its clinical presentation. Participants were black and
white men and women from four United States suburbs to enhance representativeness.
These participants were initially free of clinical CVD. Our data analysis utilized IMT
measurements that were taken at baseline and correlated with clinical events and other
clinical parameters that occurred over the next 6 years.
Utilizing a prospective observational design, health information was obtained
initially and at the subsequent follow-ups, which allowed assessment of whether a
positive association existed between one site mean IMT and CVD incidence in
asymptomatic individuals between 45-64 years of age. Particular risk factors were
initially measured and controlled for, and were then correlated to CVD event incidence.
A secondary objective addressed in this study was assessing the impact of these particular
risk factors on CVD and to see how they correlated to baseline one-site mean IMT. IMT
ultrasound examinations used in the ARIC study have been previously described in
detail.10 Definitions of CVD and risk factors have been thoroughly defined in
accordance with current medical beliefs.
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The purpose of this analysis of the ARIC database is to address a question not raised
in the previously published analyses of the ARIC Study database. One study from the
ARIC database (Chambless et al., 1997) reported three-site combined mean EMT
(TSCMI) measurements as carotid “mean IMT”, however, reporting mean IMT over a
distance of 1 cm from three sites is difficult because there is missing data from the ARIC
database about 30% of the time.7 Some researchers approach to this difficulty was to
impute IMT values to fill in the missing gaps7. In contrast to the high incidence of 30%
missing data from combined three site mean IMT, only 4% of participants in the ARIC
Study were missing data at both the left and right common carotid mean IMT. This
demonstrates that the common carotid artery has greater visualizability.10 Coupled with
the fact that average one-site CCA mean IMT (OSCMI) is easier to access, more
visualizable, and easier to measure, begs the question of whether this one site could be
used alone to determine the risk of CVD.10 This study is designed to look at this
possibility. Additionally, this study excluded any participants with any missing IMT
data, rather than imputing IMT values to fill the missing gaps (Table I). Further, a model
employing exclusion of mean IMT (Table 1) measurements of less than 0.500 mm. was
utilized and shown to increase predictivity.
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Table I
Population values for Hollander (2007), Hollander (2007), featuring
the ARIC database with non-imputed results, and results with the further
exclusion of any values <0.5 mm.

WOMEN
MEN

Non-imputed i
2686

<0.5 mm deleted2

2288

2099

4974

4366

TOTAL

2267

i

data from Hollander Study (2007): with no imputed data, participants excluded if data
missing.
2data from Hollander Study (2007): with no imputed data, participants excluded if data
missing and values <0.50 mm deleted.
The association of OSCMI to CVD incident rate was compared with the association
of TSCMI to CVD incident rate, using ROC curves, in order to assess whether the
OSCMI is reliably predictive of CVD (Table II). The area under the curve (AUC) in a
Receiver Operator Characteristic (ROC) curve quantifies predictiveness of a diagnostic
test. The AUC of the ROC curve was compared for both the OSCMI and the TSCMI
(Table III), by calculating a critical z ratio for both IMT methods. The ratio was then
compared to the z of 1.96 at an alpha of 0.05 to assess whether there was significant
difference between the ROC curves.
Further analysis addressed whether the average incremental OSCMI alone had a
reliable association to CVD incident rate at five incremental levels, with and without
adjustment for selected risk factors. New incremental cut-offs for the OSCMI values
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were created, based on proportional differences between OSCMI and TSCMI of the
participants in the non-imputed database. Comparable one-site cut-offs were determined
by calculating the difference between three separate age-group’s three-site and one-site
values, averaging these three differences, and then developing OSCMI incremental
cutoffs proportional to the incremental three-site values that were used by Chambless et
ah, (1997). Odds ratios (ORs) for both incremental one-sites and incremental three-sites
were shown both adjusted and non-adjusted for risk factors of interest. Risk factors
utilized were updated to current cut-off points where appropriate (Appendix A). Gender
specific logistic regression was used to compare the CVD events for the different levels
of one-site and three-site IMT after controlling for the potential confounders: total serum
cholesterol (TSC), HDL-cholesterol (HDL) LDL-cholesterol (LDL), triglycerides, blood
glucose, BMI, hypertension, smoking status, pack years smoked, ethanol consumption,
race and age. A dummy variable to indicate these variables was used in the logistic
Results
Predictiveness of CVD event by AUC for OSCMI and TSCMI is significant in
both men and women, both before and after the exclusion of values <0.5 mm (Table II).
Before exclusion, women show nearly statistically the same value of predictiveness of a
CVD event by OSCMI and TSCMI, while men’s values of predictiveness are statistically
significantly higher for TSCMI. Men’s values for predictiveness of a CVD event are
slightly higher than women’s with TSCMI and lower for predictiveness of a CVD event
with OSCMI values.
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Table II
Receiver Operator Characteristic (ROC) Curve Area Under the Curve (AUC) Values for
various populations utilizing OSCMI and TSCMI testing.
SIG

S1G.
POPULATION

Cl

Cl

TEST

p-value

p-value
*1

:

OSCMI

.589

.011

.511,.667

TSCMI

.604

.003

.535,.674

.526,.63
5- 'p 'y' '‘i s 'sN'-'

Non-imputed

.651

.000

.605,.698

.

comparison

OSCMI
TSCMI
Non-imputed
with exclusion
of <.5 mm
comparison

$ = 0.5331
no significant difference
between OSCMI & TSCMI
Statistically the Same

O = 0.0053
significant difference
between OSCMI & TSCMI
Statistically Different
i

"

.644*

.041

.564,.724 ! .60,4.000

.548,.660

.633*

.035

.595,.731

.604,.702

$ = 0.5543
no significant difference
between OSCMI & TSCMI
Statistically the Same

.653*

c? = 0.0575
no significant difference
between OSCMI & TSCMI
Statistically the Same

*AUC values graphically illustrated in Figure I
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Figure I

Receiver Operator Characteristic (ROC) Curves and Area Under Curve (AUC)
Non-imputed Population with Exclusion of Values <0.5 mm
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1.0

After exclusion of values <0.5 mm, all values of predictiveness of CVD events
increase for both men and women, with both OSCMI and TSCML TSCMI values remain
higher than OSCMI values for CVD event predictiveness for both men and women.
Women’s values for both OSCMI and TSCMI are slightly higher. For women, there is
not a statistically significantly difference between OSCMI and TSCMI values. For men,
there is a slightly larger difference, but there is still not a statistically significant
difference. OSCMI and TSCMI are therefore statistically significantly equal for both
women and men after exclusion of values <0.5 mm.
Table III
Comparison of the odds of CVD events for mean one-site IMT by increment, adjusted
and non-adjusted for RF, versus odds for a mean three-site IMT by increment, adjusted
and non-adjusted for risk factors, for men and for women (within non-imputed values for
the ARIC population, before and after exclusion of values <0.5mm)
A. BEFORE EXCLUSION
CCA

Model 2 (adjusted)

Model 1 (non adjusted)
Women
IMT variable

sig

OR

Women

Men

95% Cl

sig

OR

95% Cl

sig

OR

Men
95% Cl

sig

OR

95% Cl

0.086 2.175 0.897 5.272;0,004 2.041 1.263

3.299

0.291 1.660 0.648 4.255 0.026 1.770 1.069 2.930

>=0.884vs.lMT< 0.530 mm 0.196 2.023 0.696 5.886 0.5451.244 0.613

2.526

0.841 1.137 0.326 3.967 0.465 0.745 0.338 1.641

IMT > 0.885 mm

[.707,.883)vslMT<.530 mm 0.192 1.597 0.791 3.224 0.177 0.671 0.376

1.197

0.326 1.457 0.687 3.087:0.048 0.537 0.289 0.995

[.619,.707)vs.lMT<.530mm 0.246 0.645 0.307 1.353 0.055 0.555 0.304

1.012

0.227 0.619 0.285 1.347 0.025 0.472 0.245 0.911

[■53,.618)vs.lMT< 530 mm 0.058 0.480 0.224 1.026 0.008 0.410 0.211

0.796

0.067 0.479 0.218 1.052:0.002 0.335 0.166 0.678

Women
IMT variable

Model 2 (adjusted)

Model 1 (non-adjusted)

3-SITE
sig

OR

95% Cl

Women

Men
sig

OR

95% Cl

IMT > 1 mm

0.025 2.325 1.109 4.872:0.006 1.859 1.195

>=1.0 vs. IMT < 0.6 mm

0.010 3.370 1.334 8.516p.001 4.401 1.860 10.41

2.893

sig

OR

Men
95% Cl

sig

OR

95% Cl

0.234 1.634 0.728 3.665 0.069 1.541 0.967 2.455
0.186 2.050 0.708 5.933 0.037 2.790 1.066 7.300

[0.8, 1.0) vs. IMT <0.6 mm 0.083 2.050 0.911 4.613 0.0004.344 1.967

9.595

0.312 1.563 0.657 3.716|l0Q.l 3.795 1-666 8.645

[0.7, 0.8) vs. IMT <0.6 mm 0.211 1.642 0.755 3.5690.041,2.249 1.035

4.885

0.352 1.455 0.661 3.201 0.143 1.8460.812 4.196

[0.6, 0.7) vs. IMT <0.6 mm 0,393 1.343 0.683 2.639 0.247 1.595 0.723

3.519

0.451 1.307 0.652 2.621 0.352 1.473 0.651 3.333
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Table III
Comparison of the odds of CVD events for mean one-site IMT by increment, adjusted
and non-adjusted for RF, versus odds for a mean three-site IMT by increment, adjusted
and non-adjusted for risk factors, for men and for women (within non-imputed values for
the ARIC population, before and after exclusion of values <0.5mm)
B. AFTER EXCLUSION
Model 2 (adjusted)

Model 1 (non-adjusted)

CCA

j

Women
IMT variable
IMT > 0.885 mm
>=0.884vs IMT<0.53 mm
[.707,.883)vslMT<.53
mm
[.619,.707)vslMT<.53
mm
[.530,.618)vslMT<53
mm

Women

sig
OR
95% Cl
sig
OR
95% Cl
sig
OR
95% Cl
0.083 2.202 0.901 5.383! U.002S2.116 1.303 3.438 0.226 1.806 0.694 4.699iu.Qi6l 1.865 1.121 3.105
sig

OR

95% Cl

0.211 2.304 0.623 8.525 0.514 1.337 0.559 3.197 0.650 1.448 0.293 7.164 0.800 0.881 0.331

2.343

0.202 1.884 0.713 4.981

1.400

0.355 0.702 0.331 1.488 0.334 1.662 0.593 4.664 0.261 0.635 0.288

0.538 0.730 0.269 1.985 0.157 0.571

0.263 1.240 0.440 0.659 0.229 1.899 0.119 0.513 0.222

1.188

0.250 0.553 0.201 1.519t 0,037 0.416 0.182 0.949 0.345 0.601 0.208 1.732 0 022 0 353 0.145

0.859

Model 2 (adjusted)

Model 1 (non-adjusted)

3-site

Women
IMT variable

sig

OR

95% Cl

Women

Men
sig

OR

95% Cl

sig

OR

95% Cl

sig

OR

95% Cl

IMT > 1 mm

0.011 2.670 1.256 5.675? 0.00^1.841 1.165 2.909

0.108 1.974 0.861 4.52 0.082

1.534 0.948 2.48

>=1.0 vs. IMT < 0.6 mm

0.000 8.945 2.606 30.07’: 0.0015.929 2.059 17.07

0.022 6.019 1.290 28.1 0.030

3.626

[0 8. 1.0)vs IMT <0.6 mm

0.006 4.732 1.553 14.42P O.OOf 5.262 1.952 14.18

0,048 3.217 1.010 10.3 0.003

4.687 1.687 13.01

[0.7, 0.8)vs IMT <0.6 mm
[0.6, 0.7)vs IMT <0.6 mm

0.012 3.956 1.354 11 .Selllli2.907 1.096 7.706
0.028 3.076 1.127 8.393 0.245 1.815 0.665 4.957

0.051 2.978 0.994 8.92 0.083
0.048 2.819 1.010 7.87 0.304

2.468 0.890 6.845
1.720 0.612 4,837

■ *« !

Incremental analysis of OSCMI before exclusion of values < 0.5 mm (Table
III), both adjusted and non-adjusted for standard risk factors, revealed that at the highest
and lowest increments, for men, there was a significant correlation with CVD events.
Additionally, OSCMI values for men at levels (.707, .883) vs. <0.530mm and (0.619,
.707) vs. < 0.530mm were significantly correlated to CVD only when adjusted for risk
factors. There are no significant correlations of OSCMI to CVD events for women. For
TSCMI, at the incremental level of >1.0 and > 1.0 vs. < 0.6 mm there is significant
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1.13 11.6

correlation to CVD events for women. For men, the TSCMI which is non-adjusted is
correlated to CVD events at every incremental level but the lowest. When adjusted, the
increments of > 1.0 vs < .6 and (0.8, 1.0) vs < 0.6 of TSCMI for men show a significant
correlation with CVD events.
In the experience of an author from this study, when the average of right and left side
CCA mean IMT of 45-64 year old men and women with no history of CVD was
measured by an experienced reader using commercially validated edge-detection
software, the incidence of values less than 0.500 mm was 0.7%, or 1 out of 134 (72
women and 62 men). 11,12 In contrast, the incidence of average CCA mean IMT less than
0.500 mm in our exclusionary ARIC database exceeded our experience by a factor of
more than 10 fold. We, therefore, elected to also analyze the ARIC data by excluding
those participants whose average CCA mean was less than 0.500 mm.
The results of applying those exclusions for both OSCMI and TSCMI nonimputed data are described in Table II and by ROC curves A, B, C and D in Figure 1.
The most profound consequence of applying these exclusion criteria was seen in Table
Illb values of TSCMI for women, resulting in their average incremental odds ratios of
association of IMT with CVD events increasing 50%, both with and without adjustment
for standard cardiovascular risk factors. For women, there is significant correlation of
TSCMI to CVD event for all incremental levels when non-adjusted, and at three out of
five levels when adjusted. There is no correlation of OSCMI to CVD events within this
criteria for women. For men, applying this criterion decreases the number of OSCMI
incremental correlations so that these correlations exist at only the higher and lower
levels for non-adjusted and adjusted models. For men the result of implementing this
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exclusion for TSCMI resulted in the average incremental odds ratio staying the same, so
that when not adjusted all but the lowest increment is associated and when adjusted two
remain associated. The net result for correlation of TSCMI with exclusion of values
<0.5mm to a CVD event is that women’s odds ratio exceed men’s, both with and without
adjustment for standard risk factors.
The OSCMI odds ratios of less than 1.0 for both men and women before and after
application of the < 0.500 mm CCA mean IMT exclusion are inconsistent with our
OSCMI AUC and ROC findings. Our lack of access to potentially significant modifiers
such as field center adjustments and skepticism of the validity of at least some of the
CCA mean IMT measurements performed by ARIC readers casts serious doubts on the
validity of our OSCMI odds ratio findings.
Discussion
This analysis of the ARIC database shows that the ROC curves and AUC of
OSCMI are similar to those of TSCMI, supporting the evidence of the Rotterdam IMT
study that association of IMT with CVD of CCA mean IMT alone or combined three site
mean IMT are strong and similar.8 Furthermore, when we exclude from this ARIC
database those men and women participants (12%) whose average right and left CCA
mean IMT was measured as less than 0.500 mm, the odds ratio of TSCMI association of
IMT with CVD for women and men substantially improves and in fact the IMT
predictability for women exceeds that of men.
The primary goal of this data analysis was to evaluate predictivity of IMT for
CVD when limiting carotid IMT analysis to only CCA in the ARIC database. These
results were compared to similar results for all three sites (BIF, ICA, and CCA)
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combined. Chambless’ (1997) ARIC IMT analysis reported a stronger association of
IMT with CHD events for CCA mean IMT than BIF or ICA. The CHS study reported
strongest association of IMT with CVD events for combined CCA and ICA than for
either individually.13 The Rotterdam case-control population IMT study reported AUC
for CCA alone as .671 and for combined three sites as .670 and concluded that the
predictive values of the three individual sites and the combined three sites was similar. 8
Since one-site IMT scanning appears to offer so many advantages over three site IMT
scanning that is frequently used, the authors of this study sought to determine whether the
ARIC data supports the hypothesis of significant predictivy of CVD by one-site IMT.
Access was available for the average of all 11 IMT measurements and also to
each individual IMT measurement among those 11 measurements that were made for
each IMT segment visualized. This allowed the authors of this study to determine the
average age adjusted mean EMT for the CCA and each of the other two IMT segments of
the carotid artery that were visualized, captured and measured.
During the analysis of the data it became apparent that approximately 10% of
CCA mean IMT raw measurements reported in ARIC were less than 0.500 mm, of which
about 50% were less than 0.400 mm. This was perplexing since in the experience of one
investigator in this study, the incidence of CCA mean IMT less than 0.500 mm among
45-65 year old men and women was less than 1% (1 out of 134 [women age 45], men and
women with no CHD history, age 45-64, 62 men, 72 women). Though ARIC measured
their IMT segments at the peak systolic portion of the cardiac cycle when IMT thickness
would be at its smallest magnitude, the actual reduction of IMT due to this effect
compared to measurement at end diastole or at random portions of the cardiac cycle is
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only 5% (0.025 mm) and 3 % (0.015 mm), and was not considered sufficient explanation
for the disproportionately large number of CCA mean IMT measurements that were of
such small magnitude. One model of this study included exclusion of all participants on
whom CCA mean IMT was less than 0.500 mm. Doing so reduced the sample size by
about 12% but had a marked effect on improving the TSCMI odds ratios and ROC
curves, especially for women.
We found that the association of mean IMT with CVD events in ARIC was
substantially greater for men than for women on analysis of the raw IMT measurements
for participants with no missing EMT data. However when the <0.500 mm exclusion was
applied, this pattern was reversed in the TSCMI measurement. The Rotterdam casecontrol population based IMT study reported the association of IMT to CVD events as
being similar for men as for women.8 The Kuopio population based IMT study did not
include women.14 The Cardiovascular Health Study did not report separate associations
for men and women of IMT with CHD events.2,13
In our analysis of OSCMI association with CVD events, with < 0.500 mm CCA
mean IMT excluded, showed predictiveness only for men. Our analysis of three-site
association of IMT with CVD events when participants with < 0.500 mm CCA mean
IMT were excluded found predictiveness for women and men, with and without
correction for risk factors. The association of three-site combined IMT with CVD events,
when adjusted for risk factors, was attenuated, as would be expected. However,
persistence of a correlation even when adjusted supports the other literature evidence that
IMT is a predictor of CVD that is independent of standard cardiovascular risk factors
A limitation of this study was the inability to compare event rates between
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OSCMI and TSCMI due to lack of access to field centers and medication data in our
ARIC database. Confinement to odds ratio analysis rather than the more robust hazard
risk ratio was necessary since access to exact timing of cardiovascular events within the
follow-up period was not available. The analysis included only six years of follow-up
data, resulting in a smaller number of events available for our statistical analysis. In
addition, only raw IMT measurement data was included in the analysis and excluded
participants on whom any IMT data was missing. This reduced the sample size by 75%.
The Rotterdam IMT study employed similar exclusions for missing data for their
analysis. One model from this study included exclusion of all participants on whom CCA
mean IMT was measured as less than 0.500 mm. Doing so reduced the sample size by
about 12% but had a marked effect on improving the odds ratios and ROC curves,
especially for women. Because of the encouraging similarities of AUC for OSCMI and
TSCMI, which is consistent with findings of other IMT investigators, the authors of this
study believe the OSCMI odds ratio analysis had too many unexpected limitations for us
to depend on its results to draw valid conclusions.
Conclusion
CCA mean IMT alone is associated with future cardiovascular events as is threesite combined mean IMT, as shown by AUC for OSCMI and TSCMI. Since bifurcation
and internal carotid artery IMT images carry a larger likelihood of unmeasurable mean
IMT, the IMT of common carotid artery mean IMT has a practical advantage over mean
measurements of the two other sites.
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Appendix A

Medical Cut-Point Changes

High Density Lipoprotein Cholesterol: from 35 mg/dl to 40 mg/dL (men and women)
Triglycerides: from 200 mg/dL to 150 mg/dL
Diabetes: from 140 mg/dL to 126 mg/dL
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CHAPTER 5
OTHER FINDINGS
The correlation of risk factors with CVD events without adjustment for IMT is
shown in Table I Model 1. When standard risk factors alone were analyzed in terms of
their association with CVD events for both women and men, before exclusion of 0.5 mm
values, TSC had a significant association to CVD, essentially doubling the risk of a CVD
event for women (2.09) and men (1.77). There was no significant association of TSC to
CVD events after exclusion of values <.5 mm. For women, before and after exclusion of
these values, diabetes had a strong, significant association with CVD event when risk
factors were correlated without IMT within Model 1 of over two times the risk. For men.
sports activity level had a statistically significant protective association with CVD events
in Model 1, before the exclusion of <0.5 mm values only.
The effect of adjusting for these standard risk factors and adjusting for IMT in
association with CVD events is shown in Table IV Model 2. In Model 2 before exclusion
of <0.5 mm values there was a statistically significant association seen for TSC with
OSCMI and with TSCMI. For analysis with either OSCMI or TSCMI after values <0.5
mm were excluded, TSC showed no association to CVD event. Diabetes was associated
only with TSCMI and CVD event in Model 2, and only with women, before and after
exclusion of <0.5mm values. Sports activity levels were associated with TSCMI and
CVD events in Model 2, though only for men before exclusion of <0.5mm values. No
other risk factor associations, except IMT itself, existed with a CVD event within
Model 2. For IMT, before exclusion, there was a significant correlation of OSCMI with
CVD events only among women, and a significant correlation of TSCMI with CVD
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events only for men. After exclusion, both OSCMI and TSCMI showed an association for
both men and women.
Table 4
Predictiveness for CVD of Risk Factors Associated with CVD

Risk factors
Race
Age
LDL
HDL
TSC
Hypertension
Obese
Diabetes
Never Smoker
Current moker
Former Smoker
Cigarette Years
Sport Activity
Never Drank
Current Drinker
Former Drinker
Model 2
1-Site
Risk factors
Race
Age
LDL
HDL
TSC
Hypertension
Obese
Diabetes
Never Smoker
Current Smoker
Former Smoker
Cigarette Years
Sports Activity
Never Drank
Current Drinker

Model 1 (risk factors only) Before Exclusion
Men
Women
OR
Sig.
95% Cl
OR
Sig.
0.454
0.812
0.539
0.800
0.393
1.628
0.000
1.066
1.024
0.303
0.979
1.071

0.892
0.260
0.022

0.136
0.926
0.047
0.447

0.376
0.229
0.069
0.167
0.498
0.269
0.887

0.192
0.159
0.015

1.336
1.727
1.772
1.179

0.960

0.531

1.737

1.379
2.094
1.520

0.789

2.411

1.113

3.940

0.876

2.637

0.424

0.550
0.935

95% Cl
0.471

1.400

1.031

1.103

0.864

2.064

0.808

3.689

1.115

2.816

0.788

1.764

0.275

1.099

0.434

2.013

0.408

0.095

1.757

3.913

0.900

17.022

0.090
0.863
0.349
0.530
0.989
0.239

1.688

0.706

4.033

0.791

0.568

1.103

0.046

0.782

0.615

0.996

0.966
0.797
0.870

1.087

0.576

2.049

1.062

0.517

2.183

0.952
2.299

0.337

2.688

1.012

5.224

0.494

0.104

2.356

0.712

0.389

1.302

0.946

0.440

2.036

1.384

0.502

3.819

0.994

0.396

2.493

(IMT after controlling for risk factors) Before Exclusion
Men
Women
95% Cl
OR
95% Cl
Sig.
Sig.
OR

0.495
0.625
0.828
0.301
0.026

0.781

0.384

1.587

0.395

0.788

0.456

1.364

1.012

0.966

1.060

1.059

1.022

1.097

0.936

0.516

1.699

0.002
0.203

1.327

0.858

2.052

1.343

0.768

2.349

0.160

1.724

0.807

3.686

2.057

1.092

3.875

1.738

1.092

2.765

1.158

0.773

1.735

:

0.230

1.408

0.806

2.461

0.020
0.477

0.911
0.088
0.431

0.943

0.332

2.675

0.101

0.560

0.280

1.120

4.736

0.784

0.898

0.415

1.943

1.375

0.498

3.796

1.001

0.399

2.512

2.063

0.899

0.370
0.220
0.073

0.490

0.103

2.335

0.401

0.093

1.727

3.831

0.880

16.672

0.174

0.793

0.568

1.108

0.706

0.386

1.291

0.482

0.258

84

0.383
0.539
0.998
0.266
0.052
0.957
0.771

1.640

0.685

3.927

0.788

0.619

1.003

1.099

0.582

2.077

Former Drinker
1 site IMT

0.883

0.944

0.437

2.038

0.043

5.710

1.057

30.856

0.847
0.207

1.074

0.521

2.211

1.963

0.688

5.603

Predictiveness for CVD of Risk Factors Associated with CVD
Model 2 (IMT after controlling for risk factors) Before Exclusion
3-Site
Risk factors
Race
Age
LDL
HDL

ISC
Hypertension
Obese
Diabetes
Never Smoker
Current Smoker
Former Smoker
Cigarette Years
Sports Activity
Never Drank
Current Drinker
Former Drinker
3 Site IMT
Model 1
Risk factors
Race
Age
LDL
HDL

TSC
Hypertension
Obese
Diabetes
Never Smoker
Current Smoker
Former Smoker
Cigarette years
Sport Activity
Never Drank
Current Drinker

Women

Men
OR

0.574
0.545

0.815

0.400

1.661

Sig.
0.564

0.852

0.493

1.470

1.014

0.969

1.062

0.007

1.050

1.013

1.089

0.813
0.291

0.931

0.512

1.690

0.830

1.997

0.772

2.370

0.259
0.201

1.288

1.353

1.642

0.768

3.511

0.024
0.202

2.076

1.102

3.910

0.024

1.708

1.073

2.720

1.437

0.824

2.508

1.094

0.727

1.647

0.923

0.950

0.334

2.696

0.575

0.287

1.154

2.249

0.986

5.130

0.666
0.119
0.850
0.429
0.562
0.998

0.928

0.430

2.004

Sig.

0.054
0.453

OR

95% Cl

95% Cl

3.732
0.367
1.351
0.489
0.487
0.102
2.325
2.512
0.399
1.001
0.229
1.757
0.095
0.408
0.335
3.691
0.641
1.538
0.083
16.078
0.844
3.683
0.046
0.614
0.996
0.174
0.782
0.571
1.107
0.795
0.955
0.518
0.801
0.574
0.284
2.053
1.085
1.315
0.392
0.718
0.931
2.132
1.033
0.500
0.895
0.441
2.046
0.950
0.004
0.086
5.530
1.373
2.755
6.628
2.417
0.881
(risk factors only, 1-site and 3-site) With Exclusion
Men
Women
OR
95% Cl
Sig.
95% Cl
Sig.
OR
0.582
1.492
0.835
0.855
0.490
1.953
0.924
0.437
o.ooi
1.028
1.106
0.259
1.084
1.066
0.979
1.030
0.121
0.705
0.909
2.280
2.164
1.439
1.133
0.593
0.270
0.138
0.715
3.312
1.539
0.855
3.108
1.630
0.051
0.139
2.658
1.628
0.998
3.425
1.699
0.843
0.142
0.225
0.901
2.068
2.674
1.365
1.457
0.793
0.112
0.881
1.147
0.556
0.269
0.294
2.860
0.917
0.711
0.027
0.857
0.378
1.940
1.115
5.939
2.573
0.364
0.091
0.334
0.980
1.676
0.588
4.772
4.779
0.980
0.201
0.698
0.210
1.204
0.472
3.071
0.085
1.719
0.382
0.456
0.286
0.578
3.388
1.400
0.504
10.198
2.267
0.091
0.496
0.803
0.623
1.036
0.881
0.611
1.269
0.975
0.434
0.901
0.256
0.537
2.024
1.043
1.328
0.344
0.676
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Former Drinker
0.978
0.972
0.465
0.990
1.015
0.448
2.298
Predictiveness for CVD of Risk Factors Associated with CVD
Model 2 One-Site IMT (after controlling for risk factors) With Exclusion
1-Site
Risk factors
Race
Age
LDL
HDL

ISC

Sig.
0.828
0.548
0.758
0.187
0.187
0.415

M en

Women
95% Cl
OR
0.920

0.436

2.107

1.943

Sig.
0.487

OR
0.820

0.468

1.437

1.055

1.016

1.096

95% Cl

1.016

0.965

1.070

0.005

1.108

0.576

2.130

0.134

1.423

0.897

2.257

0.277
0.072

1.531

0.711

3.299

1.571

0.960

2.570

1.545

0.809

2.950

1.609

0.794

3.257

Hypertension
0.697
2.401
1.293
Obese
0.772
0.844
2.658
0.268
Diabetes
0.070
5.117
2.191
0.938
Never Smoker
0.080
Current Smoker
0.990
0.207
4.927
1.010
Former Smoker
0.208
1.714
0.084
0.380
Cigarette Years
0.328
9.568
2.121
0.470
Sports Activity Level
0.487
1.271
0.604
0.876
Never Drank
0.449
Current Drinker
0.258
1.330
0.344
0.677
Former Drinker
0.993
2.284
0.996
0.435
0.004
One Site IMT
100.07
2.364
15.38
Model 2 Three-Site IMT (after controlling for risk
3-site
Women
Sig.
OR
95% Cl
Risk factors
Race
0.932
0.968
0.456
2.053
Age
0.516
1.072
1.017
0.966
LDL
0.802
1.087
0.566
2.088
TSC
0.156
3.367
1.665
0.823
Hypertension
0.358
0.722
1.334
2.466
BMI
0.420
0.871
1.059
0.961
Obese
0.862
0.904
0.288
2.834
Diabetes
0.030
5.882
2.535
1.093
Never Smoker
0.093
Current Smoker
0.990
4.834
0.990
0.203
Former Smoker
0.214
1.735
0.085
0.385
Cigarette Years
0.370
0.440
9.053
1.996
Sports Activity
0.481
1.263
0.877
0.609
Never Drank
0.509
Current Drinker
0.298
1.374
0.697
0.354
Former Drinker
0.991
0.437
2.268
0.995
3 Site IMT
0.014
1-297
10.020
3 604
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0.186
2.013
1.326
0.873
0.138
0.279
1.194
0.577
0.595
1.824
0.350
0.799
0.409
0.353
1.642
0.576
4.681
0.698
3.071
1.204
0.472
0.514
0.554
3.259
1.344
0.113
0.814
0.631
1.050
0.962
0.835
2.094
0.551
1.074
0.967
2.173
1.016
0.475
0.039
9.282
3.138
1.061
factors) With Exclusion
Men
95% Cl
OR
Sig.
0.719
1.577
0.902
0.517
0.012
1.011
1.091
1.050
0.166
0.873
2.207
1.388
0.072

1.570

0.960

2.569

0.265
0.122
0.144
0.696
0.448
0.375
0.708
0.565
0.092
0.946
0.884
0.933
0.006

1.270

0.834

1.936

1.066

0.983

1.157

0.582

0.281

1.203

0.849

0.374

1.928

1.606

0.564

4.578

1.196

0.469

3.051

1.298

0.534

3.153

0.803

0.623

1.036

1.051

0.540

2.045

0.968

0.453

2.070

2.767

1.333

5.743

CHAPTER 6
DISCUSSION
A. GENERAL SUMMARY
Carotid ultrasound scanning is a non-invasive imaging technique found to be
effective, valid, and reliable in ascertaining the extent and severity of atherosclerotic
disease in the carotid arteries (Aminbakhash & Mancini, 1999; O’Leary & Polak, 2002).
Measurement of intima-media thickness (IMT) via ultrasound did not significantly differ
from intima-media thickness measured on pathologic examination (Pignoli, Tremoli,
Poli, Orest & Paoletti, 1986). Carotid atherosclerosis also reflects the severity and extent
of atherosclerotic disease in the coronary and other arteries throughout the body when
measured at postmortem examination (r=0.46 to 0.57) (Crouse, 2001; Pifha, Krajickova,
& Cifkova, 1999). A study done by Chambless et al. (1997) showed the association of
three-site IMT (internal, bifurcation and common carotid) to cardiovascular heart disease
events, with IMT over 1 mm resulting in several times the incident CVD hazard as those
below 0.6mm. There is difficulty, in accessing all three sites, as in the aforementioned
study by Chambless et al. (1997), leading those investigators to utilize imputation for
approximately two-thirds of the IMT measurements which constituted an individual’s
mean IMT. The common carotid consistently has greater visualizability, 91% compared
to the internal carotid’s 42% (Howard, 1993). The common carotid is also easier to
access.
This study analyzed the association of strictly the common carotid one-site IMT
measurement in association with cardiovascular disease events, as well as comparing the
one site associations with three site associations within the same population. Receiver
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operator characteristic curve’s area under the curve measures were found for both the one
and three site IMTs. One-site and three-site values were found to be significantly
positively associated with predictiveness of CVD event incidence, with the value for
women of OSCMI statistically equivalent to TSCMI for the population for which the
exclusion of values < 0.5 mm was applied. The incremental analysis of OSCMI
predictiveness of CVD events utilizing odds ratios for men demonstrated the association
of OSCMI and CVD events at levels above 0.885 mm and below 0.618 mm. For women,
there was no association of OSCMI and CVD events found.
The primary goal of this data analysis was to compare associations of IMT with
CVD in the ARIC database when limiting carotid IMT analysis to only CCA vs. all three
sites (BIF, ICA, and CCA) combined. Chambless’ ARIC IMT analysis reported a
stronger association of IMT with CHD events for CCA mean IMT than BIF or ICA,
utilizing hazard risk ratios. The CHS study (O’Leary et al., 1997) reported the strongest
association of IMT with CHD events for combined CCA and ICA than for either
individually. The Rotterdam case-control population IMT study (Del Sol et al., 2000)
reported AUC for CCA alone as .671 and for combined three sites as .670, and concluded
that the predictive values of the three individual sites and the combined three-sites was
similar.
This study utilized the large ARIC database, which the original investigators had
attempted to make generalizable. Chambless et al. (1997), upon attempting to analyze
ARIC data, decided to impute missing data, and thereby keep the sample large. For the
purposes of this study, it was decided to attempt to enhance validity by not imputing any
values. Additionally, the determination was made to exclude any IMT values below
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0.500 mm, as the occurrence of this low value in the ARIC study was approximately
10%, while in the experience of one author of this paper this occurrence is likely to be
much lower.
We found association of mean IMT with CHD events in ARIC was substantially
greater for men than for women when evaluating results on analysis of the raw IMT
measurements on participants with no missing IMT data. However when the < 0.500 mm
exclusion was applied, this pattern was reversed in the TSCMI. The Rotterdam case
control population-based IMT study (Del Sol et al., 2002) reported the association of
IMT to CHD events as being similar for men as for women. The Kuopio populationbased IMT (Salonen & Salonen, 1991) study did not include women. The Cardiovascular
Health Study (O’Leary & Polak, 2002) did not report separate associations for men and
women of IMT with CHD events.
In our analysis we found, when looking at the association of three-site combined
IMT with CVD events adjusted for risk factor, that the association was attenuated as
would be expected. However, persistence of a correlation even when adjusted supports
the other literature evidence that IMT is a predictor of CVD that is independent of
standard cardiovascular risk factors. Our analysis of three-site association of IMT with
CVD events when participants with < 0.500 mm CCA mean IMT were excluded found
predictiveness for women and men, with and without correction for risk factors. Analysis
of OSCMI association with CVD events with the same exclusion as above showed
predictiveness only for men.
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B. STRENGTHS AND LIMITATIONS
1. Strengths
The ARIC prospective study attempted maximum generalizability by including
four diverse communities and random sampling of participants. The testing protocol was
precise and reliable so that results would be reproducible. In terms of this study,
technology has improved since 1989, therefore results would likely be stronger and more
precise in assessment of IMT at this time, which would likely show even higher validity.
The ARIC Study contained a very large sample size of 13,864. This study utilized only
participants who had all raw values so therefore had a smaller sample, but the values
were not imputed, which allowed greater validity in this study. Additionally, the
occurrence of values below 0.500 mm at 10% was higher than one author’s experience of
1%, leading to this analysis being done excluding values below 0.500 mm in order to
enhance validity. There were clear CVD outcomes for this study with which to evaluate
the impact of IMT. Additionally, there were large numbers of risk factors which were
potential confounders. These risk factors were operationally defined by current standards
(Appendix A) and assessed to increase the assurance that results were indeed from
carotid IMT variations which occurred.
2. Limitations
A major limitation in the original ARIC analysis is that considerable carotid IMT
ultrasound data was missing, especially for the BIF and ICA. This is due in large part to
the lack of visuablizability for the BIF and ICA. The carotid bifurcation visualizability is
72%, and the carotid internal carotid artery visualizability is 46%. The values that could
not be visualized in some studies have been imputed (Chambless et al., 1997).
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Imputations are not exact findings, which means that these results are more imprecise.
Chambless et al. (1997) noted that only 4% of the 12,841 persons studied were missing
data at both left and right common carotids, and the CCA visualizability is 92%. This
study performed data analysis on both imputed and non-imputed samples. However, the
realization that only approximately one third of the values used for analysis in the
Chambless study were actual, non-imputed numbers, formed the basis for the new
analysis of the ARIC database by this study. Sample size was reduced from 12,841 to
4,974 with exclusion of imputed values. With further exclusion of values <0.500 mm,
sample size was reduced further still, to 4366. Power remained adequate for studies with
both exclusions, as power calculations indicated a minimum sample of 1,700.
Other limitations of this study were the inability to compare event rates between
OSCMI and TSCMI due to the lack of access to field center and medication data in the
ARIC database. Confinement to odds ratio analysis rather than the more robust hazard
risk ratio was necessary since access to exact timing of cardiovascular events within the
follow-up period was not available. This analysis included only 6 years of follow-up
data, resulting in smaller number of events available for our statistical analysis.
Another limitation was a low response rate among African Americans, leading to
a possible non-responder bias with inclusion of a somewhat healthier population.
Additionally, the sample was not a random sample of United States population, meaning
that generalizability is limited to the areas sampled (North Carolina, Mississippi,
Minnesota, and Maryland).
Finally, another possible limitation is confounding by risk factors not considered,
or not available at the time of the study, for example, CRP or homocysteine. This study
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measured what was believed by the investigators to be the key factors in atherogenesis,
“in accord with the view that atherogenesis involves primarily lipid infiltration and
thrombosis” (Robbins, Angell & Kumar, 1981; ARIC Investigators, 1989).
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CHAPTER 7
CONCLUSIONS AND RECOMMENDATIONS
A. CONCLUSIONS
IMT testing permits quantification of pre-clinical atherosclerosis and is therefore
predictive of a CVD event before there is progression of the disease sufficient to cause
clinical manifestation (O’Leary & Polak, 2002). Accessing this information, with good
validity and reliability, from a patient in a clinical setting would be very useful for a
preventive care specialist to help guide their patients. A 1999 study of men 30-50 years of
age (Vrtovev, Keger, Gadzijev, Bardorfer, & Keber) demonstrated that those who had
suffered a myocardial infarction had significantly greater carotid EMT (p=.0001) as
compared to a control group of age-matched men who did not have coronary disease.
Aminbakhsh and Mancini (1999) calculated once IMT was >0.822 mm that there is an
increased risk of myocardial infarction. The ARIC database, collected beginning in
1987, had 12,841 participants between 45-64 years of age who had not yet experienced
CHD event, who were then studied by Chambless et al. (1997). The study done by
Chambless et al. showed a strong positive association of three-site IMT (TSCMI)
(internal, bifurcation and common carotid) to cardiovascular heart disease events, with
study participants who had TSCMI values over 1 mm experiencing several times the
incident CHD hazard as those who had TSCMI values below 0.6mm.
The common carotid consistently has greater visualizability, 92% compared to
the internal carotid’s visualizability of 46% (Howard, 1993). One ARIC study
(Chambless et al., 1997), imputed approximately two-thirds of the IMT measurements to
represent an individual’s mean IMT, as only 13% of the sample had a mean IMT at all six
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carotid sites. In contrast, his study utilized the data of participants of the ARIC database
for whom all data was collectible, so that no values had to be imputed. Another benefit of
utilizing solely the common carotid artery is that it is easier to access for scanning
(Howard et al., 1993; Del Sol et al., 2002), making the test more clinically desirable. By
knowing a patient’s personal level of risk, prior to a CVD event, a preventive care
specialist is alerted and can inform a patient regarding risks and any impending danger
well before a CVD event. This affords significant preventive care guidance for a patient.
The following is a list of study conclusions:
1. Total Serum Cholesterol, one-site combined mean IMT (OSCMI) and threesite combined mean IMT (TSCMI) are the only risk factors that remain significant in
predicting cardiovascular disease events after controlling for risk factors considered in
this study, including one-site or three-site EMT.
2. ROC curve AUCs demonstrate that CCA OSCMI and TSCMI are both
similarly associated with predictiveness of CVD event. For women the AUC value for
OSCMI is statistically the same as the AUC value for TSCMI.
3. OSCMI association to CVD event for women was not demonstrated by odds
ratio at a statistically significant level for any increment of IMT discussed. TSCMI
association to CVD event for women was demonstrated at the > 1.0 vs. < .6 level when
values <0.5 mm were not excluded. When values <0.50 mm were excluded, TSCMI
association with CVD event existed at all increments for women with no adjustment for
TCRF, and at three of the lower four increments when TCRF were adjusted for.
4. For men, the highest and lowest increments of OSCMI were associated with
CVD events, whether or not <0.50 mm was excluded. Also irrespective of < 0.50 mm
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exclusion, the TSCMI for men showed all increments but the lowest to be associated with
CVD events when the values were not adjusted for TCRF. When adjusted for TCRF, the
increments > 1.0 vs <.6 and >8, 1.0 vs < .6 were associated with CVD events for the
population whether or not values <0.50 mm were excluded.
5. TSCMI was much more predictive of CVD events utilizing odds ratios, but
OSCMI had statistically the same predictiveness for women utilizing AUC ROC curves.
OSCMI and TSCMI AUC values were statistically similar for men.
B. RESEARCH RECOMMENDATIONS
There were conflicting results in this study about whether OSCMI is an equally
valid and robust a predictor of CVD events as TSCMI. ROC curves showed both tests to
be significantly predictive of CVD events, and for women to be equally predictive.
However comparative odds ratios of incremental levels of OSCMI versus TSCMI in
association with CVD events were inconsistent. Accordingly, the following questions for
future research which might be considered are:
1. Are there other OSCMI parameters/values that have as statistically significant
an association as TSCMI to CVD events? For example:
A. maximum CCA IMT
B. average of three largest maximum IMT values
2. Is there an optimal combination of IMT measures that have a statistically
significant association to CVD events, while still being utilizable in a field clinic?
3. Are there multiple independent separate rather than combined IMT
parameter cut-points that might have a statistically significant association to CVD events,
while still being utilizable in a field clinic?
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4. Do particular TCRF, when utilized along with a particular OSCMI test,
enhance predictiveness of the IMT test?
5. Once a baseline TSCMI has been established, can progression of
IMT be validly monitored with OSCMI in the field as lifestyle changes are being made?
6. Would the study of other races, in addition to black and white Americans,
yield more or less favorable results for those populations?
7. How would results for younger or older populations vary for the same tests, or
combinations of tests?
C. PRACTICE RECOMMENDATIONS
There is not yet a conclusive result stating that OSCMI, as measured in this study,
is statistically equivalently valid and robust as the TSCMI. Although the OSCMI would
be a scanning tool that would be utilizable in the field, fuller carotid scanning continues
to be a highly useful tool for prediction of CVD events when performed in the clinical
setting. CVD is the number one cause of death in this country, and atherosclerotic
vascular disease is a primary cause. As the first clinical manifestation of CVD in 50% of
individuals is acute MI or sudden death, early awareness of atherosclerotic disease before
CVD surfaces is critical. Clinical practitioners in the field, even if not performing this
test, can disseminate information regarding availability and appropriateness of this test.
Patients can be advised by preventive care specialists as to appropriate lifestyle
modifications necessary to minimize progression of atherosclerotic vascular disease.
Measurement of IMT is difficult particularly at the bifurcation and internal carotid
artery segments. Mean measurement in this study was the mean of 11 measurements on
both the right and the left for a total of 22 measurements. There are other possibilities for
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accessing a measurement that reflects the degree of atherosclerotic vascular disease.
One, or a combination of these, might be more statistically equivalent to the TSCMI.
This indicates the need for further analysis of known databases, and further investigations
with the most currently precise measurement tools in new populations, in order to better
pinpoint CVD event risk as it is associated with carotid IMT. This will allow patients to
have greater knowledge of their own atherosclerotic disease process and CVD event risk.

97

REFERENCES

Abramson, J., & Vaccarino, V., (2002). Relationship between physical activity and
inflammation among apparently healthy middle-aged and older U.S. adults.
Archives of Internal Medicine, 162, 1286-1292.
Association for Eradication of Heart Attack (AEHA), 2005. Leaders in cardiology from
AEHA’s national SHAPE task force propose a new approach to advance heart
attack prevention. Press release addressing the practice of cardiovascular
screening in apparently healthy people will be a hot topic March 5th on the eve of
the annual conference ofAmerican college of cardiology
http://www. businesswire. com/cgi-bin/mmg. cgi?eid=4835 722
Alagona, C., Soro, A., Westerbacka, J., Ylitalo, K., Salonen, J., & Salonen, R., et al.,
(2003). Low HDL cholesterol concentration is associated with increased intimamedia thickness independent of arterial stiffness in healthy subjects from families
with low HDL cholesterol. European Journal of Clinical Investigation, 33(6),
457-463.
Allan, P., Mowbray, P., Lee, A., & Fowkes, F, (1997). Relationship between carotid
intima-media thickness and symptomatic and asymptomatic peripheral arterial
disease. The Edinburgh Artery Study Stroke, 28, 348-353.
Ambrose, J., & Barua, R., (2004). The pathophysiology of cigarette smoking and
cardiovascular disease. Journal of the American College of Cardiology, 43, 17311737.

98

Aminbakhsh, A. & Mancini, G., (1999). Carotid intima-media thickness measurements:
what defines an abnormality? A systematic review. Clinical Investigation of
Medicine, 22(4), 149- 157.
Balletshofer, B., Haap, M., Rittig, K., Stock, J., Lehn-Stefan, A. & Haring, H., (2005).
Early carotid atherosclerosis in overweight non-diabetic individual is associated
with subclinical choronic inflammation independent of underlying insulin
resistance. Hormone & Metabolic Research, 37(5), 331-335.
Barter, P. (2005). Cardioprotective effects of high-density lipoproteins: the evidence
strengthens. Arteriosclerosis, Thrombosis, and Vascular Biology,_25(7), 13051306.
Baecke, J., Burema, J. & Filters,!., (1982). A short questionnaire for the measurement
of habitual physical activity in epidemiologic studies. American Journal of
Clinical Nutrition, 36, 936-942.
Beckman, J., Creager, M. & Libby, P., (2002). Diabetes and atherosclerosis:
epidemiology, pathophysiology, and management. Journal of the American
Medical Association 2878: 2570-2581.
Bolad, I. & Delafontaine, P., (2005). Endothelial dysfunction: its role in hypertensive
coronary disease. Current Opinion in Cardiology 20(4): 270-274.
Cao, J., Thach, C., Manolio, T., Psaty, B., Kuller, L., & Chaves, P., et al., (2003). Creactive protein, carotid intima-media thickness, and incidence of Ischemic stroke
in the elderly: The cardiovascular health study. Circulation, 108, 166-170.
Casiglia, E., Palatini, P., Da Ros, S., Pagliara, V., Puato, M., & Dorigatti, F., et al.,
(2000). Effect of blood pressure and physical activity on carotid artery intima99

media thickness in stage 1 hypertensives and controls. American Journal of
Hypertension 13(12): 1256-62.
Castellot, J., Wright, T. & Clowes, M., (1987). Regulation of vascular smooth muscle
cell growth by heparin and heparin sulfates. Seminars in Thrombosis and
Homeostasis 13: 489-503.
Centers for Disease Control and Prevention. National Diabetes Fact Sheet: United States,
2003. Available at:www.cdc.gov/diabetes/pubs/pdf/ndfs_2003.pdf.
Chambless, L., Heiss, G., Folsom, A., Rosamond, W., Szklo, M., & Sharrett, A., et al.,
(1997). Association of coronary heart disease incidence with carotid arterial wall
thickness and major risk factors: The atherosclerosis risk in communities (ARIC)
study, 1987-1993,(1997). American Journal ofEpidemiology 146: 483-494.
Champe, P., Harvey, R. & Ferrier, D., (2005). Biochemistry (3rd ed.). Baltimore:
Lippincott,Williams & Williams.
Cheng, K-S., Mikhailidis, D., Hamilton, G., & Seifalian, A., (2001). A review of the
carotid and femoral intima-media thickness as an indicator of the presence of
peripheral vascular disease and cardiovascular risk factors. _Cardiovascular
Research 54: 528-538.
Chobanian, A., Bakris, G., Black, H., & Cushman, (2003). The seventh report of the
joint national committee on prevention, detection, evaluation and treatment of
high blood pressure: the JNC 7 report. Journal ofAmerican Medical Association
289: 2560.
Clarkson, P., Celemajer, D., Donald, A., Sampson, M., Sorensen, K., & Adams. M. et al.,
(1996). Impaired vascular reactivity in insulin-dependent diabetes mellitus is
100

related to disease duration and low density lipoprotein cholesterol levels. Journal
of the American College of Cardiology.2% (3): 573-579.
Clowes, A., & Kamovsky, M., (1977). Suppression by heparin of smooth muscle cell
proliferation in injured arteries. _Nature, 265: 625-626.
Cohn, J., Hoke, L., Whitwam, W., Sommers, P., Taylor, L., & Duprez, D., et al., (2003).
Screening for early detection of cardiovascular disease in asymptomatic
individuals. American Heart Journal, 146: 679-685.
Crouse, J. (2001). Predictive value of carotid 2-dimensional ultrasound. American
Journal of Cardiology (2001 supplement): 27E-30E.
Dalton, S. (1997). Overweight and weight management. Maryland: Aspen Publishers.
Davis, P., Dawon, J., Riley, W. & Lauer, R., (2001). Carotid intimal-medial thickness is
related to cardiovascular risk factors measured from childhood through middle
age: The Muscatine Study.

104: 2815-2224.

Del Sol, A., Dots, M., Grobbee, D., Hofman, A. & Witteman, J., (2002). Carotid intimamedia thickness at different sites: relation to incident myocardial infarction. The
rotterdam study. European Heart Journal, 23: 934-940.
Dharmalingam, M., Deshpande, N. & Vidyasagar S., (2004). Triglyceride levels and its
correlation with carotid intima-media thickness. International Journal of
Diabetes in Developing Countries 24: 19-22.
Edelman, E., Adams, D., Kamovsky, M., (1990). Effect of controlled adventitial heparin
delivery on smooth muscle cell proliferation following endothelial injury.
Proceedings of the National Academy of Science, USA, 87: 2112-2111.

101

Ettenson, D., Koo, E., Januzzi, J., & Edelman, E., (2000). Endothelial heparan sulfate is
necessary but not sufficient for control of vascular smooth muscle cell growth.
Journal of CellularPhysiology 184: 93-100.
Ewy, G., (2004). The search for the “holy grail” of clinically significant coronary
atherosclerosis. Archives ofInternal Medicine, 164: 1266-67.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in
Adults. Executive Summary of the Third Report of the National Cholesterol
Education Program (NCEP). Expert Panel on Detection, Evaluaton and
Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
Journal ofAmerican Medical Association 285: 2486-2497.
Ferrieres, J., Elias, A., Ruidavets, J., Cantet, C., Bongard, V. & Fauvel, J., (1999).
Carotid intimal-media thickness and coronary heart disease risk factors in a low
rish \)0^\x\at\on._ Journal of Hypertension 17(6): 743-748.
Folsom, A., (1992). Fibrinogen and cardiovascular risk in the atherosclerosis risk in
communities study. In: Ernst, E., ed. Fibrinogen: a new cardiovascular risk
factor. Oxford, UK: Blackwell: 1992.
Framingham Heart Study: Design, Rationale, and Objectives, (n.d.). Retrieved March 7,
2006, From http://www.nhlbi.nih.gov/about/framingham/design.htm
Fritz, H (2005). Unpublished communication with Helmuth Fritz, MD from his personal
Intima Medial Thickening (IMT) scanning database.
Fritz H., Jutzy, R., Bansal, R. & Housten-Feenstra,L., (2005). Validation of an
automated computerized analyzing system for measuring common carotid artery

102

intima-media thickness by brightness mode ultrasound. The Journal for Vascular
Ultrasound 29(1): 21-26.
Garber, A. & Avins, A., (1999). Triglyceride concentrations and coronary heart disease.
British Medical Journal 309: 2-3.
Gariepy, J., Denarie, N., Chironi, G., Salomon, J., Levenson, J., & Simon, A., (2000).
Gender difference in the influence of smoking on arterial wall thickness.
Atherosclerosis 153(1): 139-145.
Ghiadoni, L., Taddei, S., Virdis, A., Sudano, L, Di Legge, V., & Meola, M., et al.,
(1998). Endothelial function and common carotid artery wall thickening in
patients with essential hypertension. Hypertension. 32(1): 25-32.
Goldberg, I., Mosca, L., Piano, M., & Fisher E., (2001). AHA Science Advisory: Wine
and your heart: a science advisory for healthcare professionals from the Nutrition
Committee, Council on Epidemiology and Prevention, and Council on
Cardiovascular Nursing of the American Heart Association. Circulation 103:
472-475.
Greenland, P., (2003). Improving risk of coronary heart disease: Can a picture make the
difference? Journal of the American Medical Association 289: 2270-2272.
Greenland, P., Abrams, J., Aurigemma, G., Bond, M., Clark, L., & Criqui, M., et al.,
(2000). Prevention Conferences. Beyond secondary prevention: identifying the
high-risk patient for primary prevention. Noninvasive tests of atherosclerotic
burden. Circulation 101:el6-e22.
Grundy, S. (1999). Age as a risk factor: You are as old as your arteries. American
Journal of Cardiology 83: 1455-1457.
103

Grundy, S.., Balady, G., Criqui, M., Fletcher, G., Greenland, P., & Hiratzka, L., et al.
(1998). Primary prevention of coronary heart disease: Guidance from
Framingham. Circulation 97; 1876-1887.
Hambrecht, R., Wolf, S., Gielen, S., Linke, A. Hofer, J., & Erbs, S., et al., (2000).Effect
of exercise on coronary endothelial function in patients with coronary artery
disease. New England Journal ofMedicine 342: 454-460.
Hansson, G., Robertson, A-K., & Soderberg-Naucler, C., (2006). Inflammation and
atherosclerosis Annual Review of Pathology: Mechanisms of Disease, 1: 297-329.
Heiss, G., Sharrett, A., Barnes, R., Chambless, L., Szklo, M., & Alzola, C., (1991).
Carotid atherosclerosis measured by B-mode ultrasound in populations:
associations with cardiovascular risk factors in the ARIC study. American
Journal of Epidemiology 134:250-256.
Hodis, H., Mack, W., LaBree, L., Selzer, R., Ciu, C., & Liu C., et al. (1998). The role of
carotid arterial intima-media thickness in predicting clinical coronary events.
Annals of Internal Medicine 128: 262-269. Homocysteine Studies Collaboration.
Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis^
Journal ofAmerican Medical Association. 288: 2015-2022.
Howard, G., Sharrett, A., Heiss, G., Evans, G., Chambless, L., & Riley, W., et al., for the
ARIC Investigators (1993). Carotid artery intimal-medial thickness distribution
in general populations as evaluated by B-mode ultrasound. Stroke 24: 1297-1304
Howard, G., Wagenknecht, L., Burke, G., Diex-Roux, A., Evans, G.,& McGovern, P., et
al. (1998). Cigarette smoking and progression of atherosclerosis. The

104

Atherosclerosis Risk in Communities (ARIC) Study. Journal of the American
Medical Association 279: 119.
Hu, G., Tuomilehtok J., Silventoinen, K., Barengo, N., Peltonen, M., & Jousilahi, P.,
(2005). The effects of physical activity and body mass index on cardiovascular,
cancer and all-cause mortality among 47,212 middle-aged Finnish men and
women. International Journal of Obesity 29(%)\ 894-902.
Intima-media thickness: A tool for atherosclerosis imaging and event prediction.
American Journal of Cardiology (90 supplement): 18L-21L.
Iso, H., Naito, Y., Sato, S., Kitamura, A., Okamura, T. & Sankai, T., (2001). Serum
triglycerides and risk of coronary heart disease among Japanese men and women.
American Journal of Epidemiology 153(5): 490-499.
Jialal, I, Devaraj, S. & Singh, U., (2006). C-reactive protein and the vascular
endothelium: implications for plaque instability. Journal of the American College
of Cardiology 41 (1)\ 1379-1381.
Jialal, L, Venugopal, S., Devaraj, S., Yuhanna, I., & Shaul, P (2002). Demonstration that
c-reactive protein decreases enos expression and bioactivity in human aortic
endothelial cells. Circulation \06: 1439-1444.
Kao, A., Puddey, L, Boland, L., Watson, R. & Brancati, F., (2001). Alcohol consumption
and the risk of type 2 diabetes mellitus: Atherosclerosis Risk in Communities
Study. American Journal of Epidemiology 154 (8): 748-757.
Kullo, L, & Ballantyne, C., (2005). Conditional risk factors for atherosclerosis. Mayo
Clinic Proceedings, 80(2): 219-230.

105

Lakka, T., Laukkanen, J., Rauramaa, R., Salonen, R., Lakka, H.,& Kaplan, G., et al.,
(2001). Cardiorespiratory fitness and the progression of carotid atherosclerosis in
middle-aged men. Annals of Internal Medicine 134 (1): 12-20.
LaMonte, M., (2004). Leisure-time physical activity and progression of carotid
atherosclerosis. Clinical Journal of Sport Medicine 14 (3): 189-190.
Lau, D., Dhillon, B., Yan, H., Szmitko, P., & Verma, S., (2005). Mature adipocytes and
perivascular adipose tissue stimulate vascular smooth muscle cell proliferation:
effects of weight gain and obesity. American Journal of Physiology, Heart and
Circulatory Physiology, 289 (5): H1807-1813.
Leinonen, E., Hiukka, A., Hurt-Camejo, E., Wiklund, O., Sama, S. & Hulten, L, (2004).
Low-grade inflammation, endothelial activation and carotid intima-media
thickness in type 2 diabetes. Journal ofInternal Medicine 256: 119-127.
Liu, M., Ylitalo,K., Nuotio, L, Salonen, R., Salonen, J., & Takinen, M., (2002).
Association between carotid intima-media thickness and low-density lipoprotein
size and susceptibility of low-density lipoprotein to oxidation in asymptomatic
members of familial combined hyperlipidemia families. Stroke. 33(5):1255-1260.
Lonn, Eva, (2001). Use of carotid ultrasound to stratify risk. Canadian Journal of
Cardiology 17(Supplement A): 22A-25A. Ma, J., Hennekens, C., Ridker, P., et
al. (1999). A prospective study of fibrinogen and risk of myocardial infarction in
the Physicians’ Health Study. Journal of the American College of Cardiology 33:
1347.

106

Mackness, M., Durrington, P., & Mackness, B., (2004). Paraoxonase 1 activity,
concentration and genotype in cardiovascular disease. Current Opinion in
Lipidology, 15: 399-404.
Magyar, M., Paragh, G., Katona, E., Valikovics, A., Seres, I., & Csida, L, (2004). Serum
cholesterols have a more important role than triglycerides in determining intimamedia thickness of the common carotid artery in subjects younger than 55 years
of age. Journal of Ultrasound Medicine 23: 1161-1169.
Mancini,G., Dahlof, B., & Diez, J., (2004). Surrogate markers for cardiovascular
disease: structural markers. Circulation 109 (supplement IV: IV-22-IV-30).
Manson, J., Colditz, G., Stampfer, M, Willet, W., Rosner, B., & Monson, R., et al.,
(1990). A prospective study of obesity and risk of coronary heart disease in
women. New England Journal of Medicine 322: 882-889.
Markus,R. Mack, Wl, Axen, S., Hodis, H., (1997). Influence of lifestyle modification on
atherosclerotic progression determined by ultrasonographic change in the
common carotid intima-media thickness (Monitored Atherosclerosis Regression
Study, MARS) American Journal of Clinical Nutrition. 65 (4): 1000-1004.
Martinez-Vila, E., Paramo, J., Beloqui, O., Orbe, J., Irimia, P. & Colina, I., (2003).
Independent association of fibrinogen with carotid intimae-media thickness in
asymptomatic subjects. Cerebrovascular Diseases 16 (4): 356-362.
McArdle, W., Katch. F., & Katch V., (2001). Exercise physiology: Energy, nutrition
and human performance (5th ed.) Baltimore: Lippincott, Williams & Williams.
McGill, H., & Me Mahan, C., (2003). Starting earlier to prevent heart disease. Journal
ofAmerican Medical Association. 290(17): 2320-2321.
107

McNamara, I, Molot, M., Stremple, J. & Cutting R. (1971). Coronary artery disease in
combat casualties in Vietnam. Journal ofAmerican Medical Association 216:
1185-1187.
Mitka, M., (2003). Imaging to diagnose cardiovascular disease. Journal of the American
Medical Association. 289: (3).
Mukamal, K., Kronmal, R., Mitleman, M., O’Leary, D., Polak, J., & Cushman, M.,
(2003). Alcohol consumption and carotid atherosclerosis in older adults: the
Cardiovascular Health Study. Arteriosclerosis, Thrombosis, & Vascular Biology
23(12): 2252-9.
Murray, C. & Lopez, A., (1996). The global burden of disease: a comprehensive
assessment of mortality and disability from diseases, injury and risk factors in
1990 and projected to 2020. Cambridge: authors.
Nash, D. (2005). C-Reactive protein: A promising new marker of cardiovascular risk?
Consultant 453-460.
National Cholesterol Education Program (2001). Third Report of the NCEP Expert Panel
on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
(Adult Treatment Panel III) National Heart, Lung, and Blood Institute. National
Institutes of Health, NIH Publication No. 01-3670.
National Institute of Health News Release (2002) NHLBTs Framingham Heart Study
Finds Strong Link Between Overweight/Obesity and risk for Heart Failure.
Retrieved March, 7, 2006, from http://www.nhlbi.nih.gov/new/press/02-07-

108

Niebauer, J., Maxwell, A., Lin, P., Wang, D., Tsas, P., & Cooke, J., (2003). NOS
inhibition accelerates atherogenesis: reversal by exercise. American Journal of
Physiology, Heart and Circulatory Physiology 285: H535-H540.
Nieman, D., (2001). Exercise testing and prescription: a health related approach (4th
ed.). Mountain View: Mayfield Publishing Company.
O’Connor, A., Rusyniak, D., & Bruno, A., (2005). Cerebrovascular and cardiovascular
complications of alcohol and sympathomimetic drug abuse. Medical Clinics of
North America. 89 (6): 1242-1358.
O’Leary, D., & Polak, J. (2002). Intima-media thickness: a tool for atherosclerosis
imaging and event prediction. American Journal of Cardiology (90 supplement):
18L-21L.
O’Leary, D., Polak, J., Kronmal, R., Manolio, T., Burke, G. & Wolfson, S.,
(1999).Carotid artery intima and media thickness as a factor for myocardial
infarction and stroke in older adults. 1992 Cardiovascular Health Study
Collaborative Research Group (CHS). NewEngland Journal of Medicine, 340:
14-22.
Oren, A., Vos, L., Uiterwaal, C., Grobbee, D. & Bots, M., (2003). Cardiovascular risk
factors and increased carotid intima-media thickness in healthy young adults: the
atherosclerosis risk in young adults (ARYA) study. Archives of Internal
Medicine, 163: 1787-1792.
Pai, J., Pischon, T., Ma, J., Manson, J., Hankinson, S., & Joshipura, K., et al., (2004).
Inflammatory markers and the risk of coronary heart disease in men and women.
New England Journal of Medicine 351 (25): 2599-2610.
109

Palinski, W. & Napoli, C., (2002). The fetal origins of atherosclerosis: maternal
hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during
pregnancy influence en utero programming and postnatal susceptibility to
atherogenesis. The Federation of American Societies for Experimental Biology,
16: 1348-1360.
Pate, R., Pratt, M., Blair, S., Haskell, C, Macera, C., & Bouchard, D., et al., (1995).
Physical activity and public health. A recommendation from the Centers for
Disease Control and Prevention and the American College of Sports Medicine.
Journal of American Medical Association 273(5): 402-407.
Pauletto, P., Palatini, P., Da Ros, S., Pagliara, V., Santipolo, M., & Baccilliere, S., et al.,
(1999). Factors underlying the increase in carotid intima-media thickness in
borderline hypertensives. Arteriosclerosis, Thrombosis and Vascular Biology
19(5): 1231-1237.
Penckofer, S., Filliung D., & Labropoulos, N., (2005). Non-invasive cardiovascular risk
assessment in women with type 2 diabetes. Journal of Vascular Nursing. 23 (1):
2-7
Pignoli, P., Tremoli E., Poli A., Oreste P., & Paoletti R., (1986). Intimal plus medial
thickness of the arterial walls: A direct measurement with ultrasound imaging.
Circulation 74\ 1399-1406.
Pit’ha, J., Krajickova, D., & Cifkova, R., (1999). Intima-media thickness of carotid
arteries in borderline hypertensives. Journal of Neuroimaging 9: 78-82.
Poredos, P, (2004). Intima-media thickness: Indicator of cardiovascular risk and measure
of the extent of atherosclerosis. Vascular Medicine 9: 46-54.
110

Poredos, P., Kek, A., & Verhovec, R., (1997). Morphological and functional changes of
the arterial wall in subjects at risk of atherosclerosis and in patients with
peripheral arterial occlusive disease. FASA 26: 271-276.
Poredos, P., Orehek, M., & Tratnik, E., (1999). Smoking is associated with dose-related
increase of intima-media thickness and endothelial dysfunction. Angiology 50:
201-208.
Raitakari, O., Juonala, M., Kahonen, M., Taittonen, L., Laitinen, T., & Maki-Torkko, N.
et al.,(2003). Cardiovascular risk factors in childhood and carotid artery intimamedia thickness in adulthood: the cardiovascular risk in young firms study.
Journal of the American Medical Association 290 (17): 2277-2283.
Redberg, R., Vogel, R., Criqui, M., Herrington, D., Lima, J., & Roman, M., (2003). 34th
Bethesda Conference: Task Force #3: What is the spectrum of current and
emerging techniques for the non-invasive measurement of atherosclerosis?
Journal ofAmerican College of Cardiology 41: 1885-1917.
Rhoades & Pflanzer (1996). Human physiology. (3rd ed). Orlando: Harcourt, Inc.
Ridker, P & Cook, N., (2004). Clinical usefulness of very high and very low levels of
CRP across the full range of Framingham risk scores. Circulation 109: 19551959.
Riley, W., (2002). Carotid intima-media thickness: risk assessment and scanning
protocol. European Heart JournaX. 23: 916-918.
Rimm, E, Stampfer, M., Giovannucci, E., Ascherio, A., Spiegelman D., & Colditz, G, et
al., (1995). Body size and fat distribution as predictors of coronary heart disease

111

among middle-aged and older US men. American Journal of Epidemiology 141:
1117-1127.
Robbins, S., Angell, M, & Kumar, V, (1981). Basic Pathology. (3rd ed.) Philadelphia:
WB

Saunders.

Rubin, E., & Farber, J., (1999). Pathology (3rd ed). Philadelphia: Lippincott-Ravin
Publishers.
Salonen R.& Salonen, J., (1991). Determinants of carotid intima-media thickness: a
population-based ultrasonography study. Journal ofInternal Medicine 229: 223231.
Schillinger, M., Exner, M., Mlekusch, W., Sabeti, S., Amighi, J., & Nikowitsch, R., et al.,
(2005). Inflammation and carotid artery: risk for atherosclerosis study
(ICARAS). Circulation 111(17): 2203-2209.
Schulte-Altedomeburg, G., Droste, D., Felszeghy, S., Kellerman, M, Popa, V., &
Hegedus, K. et al., (2001). Accuracy of in vivo carotid b-mode ultrasound
compared with pathological analysis: intima-media thickening, lumen diameter
and cross-sectional area. Stroke 32(7): 1520-1524.
Smith, E., Keen, G., Grant, A. & Stirk, C., (1990). Fate of fibrinogen in human arterial
intima. Arteriosclerosis, 10:263.
Smith, J., (2001). Exercise and Atherogenesis. Exercise & Sport Sciences Review.
29(2): 49-53.
Stabouli, S., Kotsis, V., Papamichael, C., Constantopoulos, A & Zakopoulos, N., (2005).
Adolescent obesity is associated with high ambulatory blood pressure and

112

increased carotid intimal-medial thickness. The Journal of Pediatrics 147(5):
651-656.
Stensland-Bugge, E., Bonaa,K., & Joakimsen, O., (2001). Age and sex differences in the
relationship between inherited and lifestyle risk factors and subclinical carotid
atherosclerosis: the Tromso study. Atherosclerosis 154 (2): 437-48.
Sugo, A., Nakajima, S., Kurata, T., Mokuno, H., Daida, H. & Yamaguchi, H. (1997).
Ultrasonographic assessment of carotid atherosclerosis emphasizing the variety of
intimal-medial thickness and the relationship with coronary risk factors. Journal
of Cardiology 30 (6): 321-329.
Swan, L., Bimie, G., Inglis, J., Connell, J., & Hillis, W., (2003). The determination of
carotid intima-media thickness in adults—a population-based twin study.
Atherosclerosis, 166 (\)\ 137-141.
Tanaka,H., Dinenno, F., Monahan, K., DeSouzaC., & Seals, D., (2001). Carotid
artery wall hypertrophy with age is related to local systolic blood pressure in
healthy men. Arteriosclerosis, Thrombosis, and Vascular Biology 2\ (1): 82-87.
Taniwaki, H. Kawagishi, T., Emoto, M., Shoji, T., Kanda, H., & Maekawa, K., et
al.,(1999). Correlation between the intima-media thickness of the carotid artery
and aortic pulse-wave velocity in patients with type 2 diabetes, vessel wall
properties in type 2 diabetes. Diabetes Care 22(11): 1851-1857.
Teno, S., Uto, Y., Nagashima, H., Endoh, Y., Iwamoto, Y., & Omori, Y., et al., (2000).
Association of postprandial hypertriglyceridemia and carotid intima-media
thickness in patients with type 2 diabetes. Diabetes Care 23: 1401-1406.

113

The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study:
Design and Objectives (1989). American Journal of Epidemiology 129: 687-702.
The Framingham Heart Study: The Town That Changed America’s Heart, (n.d.).
Retrieved February 2, 2006 from http://www.framingham.com/heart.htm
Thompson, P., Buchner, D., Pina, L, Balady, G., Williams, M., & Marcus, B., Exercise
and physical activity in the prevention and treatment of atherosclerotic
cardiovascular disease (The American Heart Association scientific statement: A
statement from the council on clinical cardiology and the council on nutrition,
physical activity and metabolism [subcommittee on physical activity]).
Circulation, 107: 3109-3126.
Toth, P. (2005). The “good cholesterol”: high-density lipoprotein. Circulation 111(5):
e89-e91.
Tsimikas, S., & Witzum, J., (2002). Shifting the diagnosis and treatment of
atherosclerosis to children and young adults: a new paradigm for the 23rd century.
Journal of the American College of Cardiology 40: 12.
Urbina, E., Srivivasan, Tang, R., Bond, G., Kieltyka, L., & Berenson, G., (2002). Impact
of multiple coronary risk factors on the intima-media thickness of different
segments of carotid artery in healthy young adults (Bogalusa Heart Study).
American Journal of Cardiology 90: 953-958.
Visona, A., Pesavento, R., Lusiani, L., Bonanome, A., Cemetti, C., & Rossi, M., et al.,
(1996). Intima-media thickening of common carotid artery as an indicator of
coronary artery disease. Angiology 47: 61-66.

114

von Eckardstein, A., Hersberger, M. & Rohrer, L., (2005). Current understanding of the
metabolism and biological actions of HDL. Clinical Nutrition and Metabolic
Care 8(2): 147-152.
Voutilainen, S., Alfthan, G., Nyyssonen, K., Salonen R., & Salonen, J., (1998).
Association between elevated plasma total homocysteine and increased common
carotid artery wall thickness. Annals of Medicine 30 (3): 300-306.
Wagenknecht, L., D’Agostino, R., Haffner, S., Savage, P., & Rewers, M., (1998).
Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the
Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 21: 1812-1818.
Wagenknecht, L., Zaccaro, D., Espeland, M., Karter, A., O’Leary D., & Haffner, S.,
(2003). Diabetes and progression of carotid atherosclerosis: the insulin resistance
atherosclerosis study. Arteriosclerosis, Thrombosis & Vascular Biology. 23 (6):
1035-1041.
Waters, D., Lesperance., J., Gladstone, P., Boccuzzi, S., Cook, T., Hudgin, R. et al.,
(1996). Effects of cigarette smoking on the angiographic evolution of coronary
atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial
(CCAIT) Substudy. Circulation 94: 614.
Wattanakit, K., Folsom, A., Chambless, L., & Nieto, J., (2005). Risk factors for
cardiovascular event recurrence in Atherosclerosis Risk in Communities (ARIC)
study. American Heart Journal 149 (4): 606-612.
Wendelhag, I., Wiklund, O., & Wikstrand, J., (1995). Intima-media thickness after
cholesterol lowering in familial hypercholesterolemia. A three-year ultrasound
study of common carotid and femoral arteries. Atherosclerosis 115: 225-236.
115

Wheaton, J.,& Pinkstaff, S., (2006). Atherosclerotic vascular disease and diabetes in the
older adult Part 1: understanding pathogenic mechanisms and identifying risk
factors. Clinical Geriatrics, \A {\)\ 17-24.
Whitney, E., Cataldo, C, & Rolfes,S., (2002). Understanding Normal and Clinical
Nutrition, (6th ed.). Belmont: Wadsworth Group.
Wilson, P., D’Agostino, R., Levy, D., Belanger, A., Silbershatz, H., & Kannel, W.,
(1998). Prediction of coronary heart disease using risk factor categories.
Circulation 97: 1837-1847.
Ylitalo, K., Syvanne, M., Salonen, R., Nutotio, IT., Taskinen, M., Salonen, J., (2002).
Carotid artery intima-media thickness in Finnish families with familial combined
)\yyQx\vp\<lQm\di. Atherosclerosis. 162 (1): 171-178.
Yamasaki, Y., Kodama, M., Nishizawa, H.,Sakamoto, K., Masuhisa, M., Kajimoto, Y et
al., (2000). Carotid intima-media thickness in Japanese type 2 diabetic subjects:
predictors of progression and relationship with incident coronary heart disease.
Diabetes Care 23(9): 1310-1315.
Zakopoulos, N., Tsivgoulis, G., Barlas, G., Papmichael, C., Spengos, K., Manios, E, et
al., (2005).Time rate of blood pressure variation is associated with increased
common carotid artery intima-media thickness. Hypertension 45(4): 505-512.
Zimmerman,M., & McGeachie, J., (1987). The effect of nicotine on aortic endothelium.
A quantitative ultrastructural study. Athrosclerosis 63: 33-41.
Zubrod, G., & Holman, J. (2004). Novel biochemical markers of cardiovascular risk: a
primary care primer Consultant, 15 09-1513.

116

